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                  SUMMARY 
 
 
 Compared with Staphylococcus aureus, S. epidermidis does not produce as many 
toxins and tissue-damaging exoenzymes and S. epidermidis infections may rarely become 
life-threatening. However, S. epidermidis has gained substantial interest in recent years 
because it is now considered as the major cause of device-related infections, infections 
which have increased in number, owing to the increased use of such devices. 
 The ability to form biofilms on medical implant surfaces is considered the main 
virulence factor of S. epidermidis. Biofilms are notoriously resistant to both immune 
system attack and antimicrobial agents. Currently, the only completely effective method 
for curing biofilm infections is to remove the infected device, a risky, costly and stressful 
procedure. 
 Different strategies are used to combat biofilm infections. The traditional 
approach to prevent biofilm formation is local administration of bactericidal agents. 
However, compared to their planktonic counterparts, bacteria within a biofilm are up to a 
1000 times more resistant to antimicrobial agents. Immunoprophylaxis and 
immunotherapy targeting proteins and surface components that are expressed in vivo and 
are important for biofilm formation are promising new approaches to prevent and treat 
biofilms. Antibodies against extracellular macromolecules and surface binding proteins 
essential for cell-surface and cell-cell interaction and adhesion, such as PIA, teichoic 
acids, Fbe and Aap and vaccination of rats with purified PIA/PNAG have been shown to 
prevent biofilm formation. An advantage of immunotherapeutic methods is the lesser risk 
for the development of resistance. 
 In this study, using a new approach called “reverse vaccinology” we tried to 
identify new potential targets for immunotherapy against S. epidermidis biofilms. The 
first step in reverse vaccinology is the identification of the complete repertoire of antigens 
that are expressed on the surface. Using an in silico procedure, 57 proteins have been 
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identified as S. epidermidis ‘surface-exposed proteins’ (Ses) of which 32 were annotated 
as (conserved) hypothetical. From these, 13 proteins were selected based on protein size, 
number of antigenic determinants and the role in S. epidermidis biofilm formation and 
pathogenesis of the protein family to which the candidate protein belongs. 
 The presence of genes coding for the 13 selected proteins (ses genes) in clinical 
and commensal isolates of S. epidermidis was investigated by PCR. Using the previously 
described in vitro and in vivo rat models for foreign body infections (FBI) (Vandecasteele 
et al. 2001;Vandecasteele et al. 2002), the expression of selected genes was investigated 
in planktonic and sessile bacteria during FBI. Seven genes were present in all tested 
isolates, whereas 6 genes were absent in some of the isolates. The in vitro and in vivo 
expression patterns of ses genes varied widely. 
 Out of 13 selected proteins, 5 proteins of which the function had not yet been 
characterized include 3 LPXTG proteins and the 2 largest ABC transporters were selected 
for the in vitro biofilm inhibition studies. The extracellular parts of these 5 selected Ses 
proteins were cloned, expressed, purified and polyclonal rabbit antibodies against them 
were raised. Using ELISA and western blotting techniques, expression of the selected 5 
proteins on the surface of S. epidermidis cells was investigated. Total IgGs were isolated 
from pre- and hyperimmune sera and used in a semi-quantitative microtiter plate method 
to evaluate the effect of different anti-Ses IgGs on S. epidermidis biofilm formation. It 
was shown that these proteins are surface-exposed, except for SesK and SesM which 
might be surface-exposed proteins which expressed under specific, unknown 
circumstances. Maximum inhibition of initial attachment and overnight biofilm formation 
on polystyrene surface was achieved by the total IgGs purified from serum of the rabbit 
immunized with rSesC. 
 SesC, against which antibodies exhibited the highest inhibition of biofilm 
formation in vitro, was selected for further investigation. Specific anti-SesC IgGs (αSesC-
IgGs) were isolated from total IgGs isolated from hyper immune serum of rabbit 
immunized with rSesC using antigen-affinity purification. Conventional fluorescence 
microscopy was used to confirm SesC protein expression on the surface of sessile and 
planktonic S. epidermidis bacteria in vitro. The effect of different concentrations of 
αSesC-IgGs was tested in vitro on primary attachment, overnight biofilm formation and 
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established (1-day old) biofilms of different S. epidermidis strains. We also tested the 
effect of αSesC-IgGs on established biofilms of S. epidermidis in the in vivo rat model for 
FBI. Finally, rats were immunized with rSesC and the effect of immunization on FBI was 
evaluated. In vitro experiments showed that rabbit polyclonal αSesC-IgGs could 
significantly reduce initial attachment, and prevent development of early and established 
biofilms of S. epidermidis on the abiotic surface of polystyrene plates. In vivo 
experiments showed the efficiency of active and passive immunization against SesC on S. 
epidermidis biofilm formation on the polyurethane catheters. 
 To unravel the structure and function of SesC, different bioinformatics tools were 
used and we studied the effect of expression and overexpression of sesC in the sesC-
negative strain S. aureus RN4220 and in the sesC-positive strain S. epidermidis RP62A 
on biofilm formation and adherence to host matrix proteins. We showed that S. aureus 
RN-transformants expressing SesC can bind fibrinogen (Fg) but not other extracellular 
matrix (ECM) proteins better than their parental strain and that αSesC-IgGs could 
significantly reduce the Fg-binding ability of RN-transformants expressing SesC and of 
the RP62A wild type and transformants. 
 In conclusion, our findings revealed that SesC represents a promising target for 
prevention and treatment of S. epidermidis biofilms by affecting primary attachment, 
biofilm accumulation and detachment. SesC might be a potential Fg-binding 
MSCRAMM (microbial surface components recognizing adhesive matrix molecules), 
which plays a role in attachment to both biotic and abiotic surfaces. However, further 
investigation is necessary to characterize the structure and identify the precise role of 
SesC in biofilm formation and the mechanism of function of αSesC-IgG antibodies in 
vivo. 
 
 
 
 
 
 
 
 SUMMARY  
 
 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SAMENVATTING  
 
 
15 
 
 
 
                SAMENVATTING 
 
 
 Vergeleken met Staphylococcus aureus, is S. epidermidis een species die veel 
minder weefselbeschadigende toxines en exo-enzymen produceert. S. epidermidis 
infecties zijn ook zelden levensbedreigend. S. epidermidis geniet recent echter stijgende 
belangstelling, omdat deze stafylokok nu wordt beschouwd als de belangrijkste oorzaak 
van vreemdlichaaminfecties, die wegens het toenemend gebruik van biomaterialen zijn 
toegenomen. 
 De mogelijkheid om een biofilm te vormen op medische implantaatoppervlakken 
wordt beschouwd als de belangrijkste virulentiefactor van S. epidermidis. Biofilmen zijn 
beduidend minder gevoelig voor antibiotica. De enige echt efficiënte methode om 
biofilminfecties te genezen, is het besmette vreemdlichaam te verwijderen, een 
risicovolle, moeilijke en dure procedure. 
 Verschillende strategieën worden gebruikt ter bestrijding van biofilminfecties. 
Lokaal of systemisch gebruik van bactericide agentia is de traditionele aanpak om 
biofilmvorming te voorkomen of te genezen. In vergelijking met hun planktonische 
tegenhangers, zijn bacteriën in een biofilm echter tot duizend keer beter bestand tegen 
antimicrobiële agentia. Immuunprofylaxis gericht tegen eiwitten die deel uitmaken van 
het celoppervlak en die tot expressie komen ‘in vivo’ en bijgevolg belangrijk zijn voor de 
vorming van biofilm is een veelbelovende nieuwe benadering voor de preventie en 
behandeling van biofilmen. Er werd reeds aangetoond dat antilichamen tegen 
extracellulaire macromoleculen zoals PIA, teichoïnezuren, Fbe en Aap, die essentieel zijn 
voor de interactie tussen het bacteriële celoppervlak en het vreemdlichaam en tussen 
bacteriën in de biofilm onderling, en vaccinatie van ratten met gezuiverde PIA/PNAG, 
biofilmvorming kunnen voorkomen. Een voordeel van immuuntherapeutische methoden 
is het verminderde risico op de ontwikkeling van resistentie. 
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 In deze studie hebben we via "reverse vaccinology" geprobeerd nieuwe potentiële 
doelen voor immuuntherapie tegen S. epidermidis biofilmen te identificeren. De eerste 
stap in deze ‘reverse vaccinology’ is de identificatie van het volledige repertoire van 
antigenen die op het oppervlak tot expressie worden gebracht. Met behulp van een ‘in 
silico’ procedure, werden 57 eiwitten geïdentificeerd als oppervlakteeiwitten van S. 
epidermidis (Ses) waarvan 32 eiwitten geannoteerd zijn als eiwitten met ongekende 
functie. Uit deze groep werden 13 eiwitten geselecteerd op basis van grootte, aantal 
antigene determinanten en de rol in S. epidermidis biofilmvorming en pathogenese van de 
eiwitgroep waartoe het kandidaat-eiwit behoort. 
 Na de ‘in silico’ selectie van potentiële vaccinantigenen, is de volgende stap het 
valideren van de geselecteerde proteïnen via analyse van de expressie ‘in vitro’ en ‘in 
vivo’. De aanwezigheid van deze 13 genen in klinische en commensale isolaten van S. 
epidermidis werd onderzocht en - met onze eerder beschreven ‘in vitro’ en ‘in vivo’ 
ratmodellen voor vreemdlichaaminfecties – werd de expressie van deze 13 genen 
onderzocht in planktonische en sessiele bacteriën tijdens de vreemdlichaaminfecties. 
 De expressiepatronen ‘in vitro’ en ‘in vivo’ van de ses genen zijn zeer gevarieerd. 
Daarom, op basis van de hierboven genoemde kenmerken, werden 5 van deze 13 eiwitten 
geselecteerd; 3 eiwitten met een LPXTG sequentie en een niet-gekende rol in 
biofilmvorming en de twee grootste ABC transportereiwitten, eveneens met ongekende 
functie. Het extracellulaire deel van deze 5 geselecteerde Ses eiwitten werd gekloond, tot 
expressie gebracht en gezuiverd en polyklonale antilichamen tegen deze eiwitten werden 
opgewekt in konijnen. De antilichamen werden geïsoleerd uit pre- en hyperimmuun sera 
en deze werden gebruikt in een semi-kwantitatieve microtiterplaat assay voor het 
evalueren van het effect van verschillende anti-Ses-antilichamen op S. epidermidis 
biofilmvorming. 
 De hoogste remming van de ‘in vitro’ biofilmvorming werd gevonden voor de 
anti-SesC antilichamen. SesC werd daarom voor nader onderzoek geselecteerd. 
Specifieke anti-SesC antilichamen werden geïsoleerd uit de totale antilichaamfractie uit 
hyperimmuun serum van konijnen via affiniteitschromatografie met recombinant SesC. 
Conventionele fluorescentiemicroscopie werd gebruikt om de expressie van SesC op het 
oppervlak van sessiele en planktonische S. epidermidis bacteriën ‘in vitro’ te bevestigen. 
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Het effect van verschillende concentraties van anti-SesC antilichamen ‘in vitro’ op 
primaire aanhechting, biofilmvorming tijdens overnacht incubatie en op mature (1-dag 
oude) biofilmen van verschillende S. epidermidis stammen werd getest. We testten ook 
het effect van anti-SesC antilichamen op mature biofilmen van S. epidermidis in het ‘in 
vivo’ rat model voor vreemdlichaaminfecties. Tot slot hebben we ook ratten 
geïmmuniseerd met SesC en het effect van deze immunisatie op vreemdlichaaminfecties 
bij ratten geëvalueerd. 
 Om de structuur en de functie van SesC te ontrafelen, werden verschillende bio-
informatica hulpmiddelen gebruikt en hebben we het effect bestudeerd op 
biofilmvorming en aanhechting aan gastheermatrixeiwitten van de expressie van SesC in 
de sesC-negatieve S. aureus RN4220 en het effect van overexpressie in de sesC-positieve 
S. epidermidis RP62A. Er werd aangetoond dat de S. aureus RN-transformanten die SesC 
tot expressie brengen beter binden aan fibrinogeen maar niet aan andere extracellulaire 
matrixproteïnen. Bovendien konden we observeren dat anti-SesC antilichamen deze 
binding significant verminderden. 
 Uit onze bevindingen blijkt dat SesC een veelbelovend doelwit is voor preventie 
en behandeling van S. epidermidis biofilmen via interactie met de primaire aanhechting, 
accumulatie en loslating. SesC is mogelijk een fibrinogeenbindende MSCRAMM 
(microbial surface components recognizing adhesive matrix molecules) en speelt een rol 
in aanhechting aan zowel biotische als abiotische oppervlakken. Verder onderzoek is 
echter noodzakelijk om de structuur en de precieze rol van SesC in biofilmvorming te 
karakteriseren alsook het werkingsmechanisme van de anti-SesC antilichamen in vivo. 
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1. General introduction 
 
 
1.1. The genus Staphylococcus 
In 1878, Robert Koch was the first to describe Staphylococcus spp. in human pus. 
In 1880, Pasteur cultivated Staphylococcus spp. in a liquid medium. Alexander Ogston 
named them and demonstrated that they were pathogenic, causing acute and chronic 
abscesses in mice and guinea pig. In 1884, Rosenbach described the two pigmented 
colony types of Staphylococcus spp. and proposed the appropriate nomenclature: S. 
aureus (yellow) and S. albus (white) which was subsequently changed to S. epidermidis. 
Staphylococcus spp. are non-motile, non-spore forming, Gram-positive spherical 
bacteria about 1 micrometer in diameter that are members of the bacterial family 
Staphylococcaceae. Staphylococcus spp. are capable of growth both aerobically and 
anaerobically (facultative anaerobes). All species can grow in the presence of bile salts, 
and are catalase positive. 
Staphylococcus spp. are normal inhabitants of the skin and mucous membranes of 
humans and other organisms (Piette and Verschraegen 2009). So far, more than 40 
species and subspecies in the genus Staphylococcus spp. have been identified (Trulzsch et 
al. 2007). This genus is divided into two groups according to production of enzyme 
coagulase that coagulates plasma: coagulase-positive, including S. aureus and S. 
intermedius; and numerous coagulase-negative Staphylococcus (CNS) species. 
Currently, there are more than 40 recognized species of CNS. Of 40 CNS species 
validly published, about 16 species are indigenous in humans; including S. cohnii, S. 
saprophyticus, S. sciuri, S. xylosis, S. auricularis, S. capitis, S. caprae, S. epidermidis, S. 
haemolyticus, S. hominis, S. lugdunensis, S. pasteuri, S. saccharolyticus, S. schleiferi, S. 
simulans, S. warneri (von Eiff et al. 2001). 
 
 
1.2. Coagulase-negative staphylococci infections 
Compared with S. aureus, the most common cause of staphylococcal infections, 
CNS do not produce as many toxins and tissue-damaging exoenzymes and have long 
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been regarded as apathogenic and harmless commensals of man (Akiyama et al. 
2000;Huebner and Goldmann 1999;Vuong and Otto 2002). CNS are now considered as 
an important causative agents of nosocomial bacteremias, infections of intravascular 
catheters and indwelling devices especially in neonates, immunocompromised and 
seriously ill patients, osteomyelitis, endocarditis, and wound infection following 
cardiothoracic surgery in the absence of prostheses (Huebner and Goldmann 
1999;Knausz et al. 2005;Otto 2004b;Piette and Verschraegen 2009;Rogers et al. 
2009;Schulin and Voss 2001;von Eiff et al. 2002). Among the CNS, S. epidermidis is the 
most frequently isolated, making up three-fourths of the CNS recovered from clinical 
specimens and accounts for approximately 75% of the infections caused by CNS. 
 
 
1.3. Clinical importance of S. epidermidis 
For the following reasons, S. epidermidis is now considered as a commensal 
opportunistic pathogen and has gained substantial interest in recent years; 
- S. epidermidis is the major pathogen of the CNS category and comprises 65-
90% of all Staphylococcus spp. recovered from human sources (Huebner and 
Goldmann 1999). 
- Approximately 180 million peripheral intravascular catheters and 7 million 
central venous catheters (CVC) are used annually in the United States alone 
(Raad et al. 2000). Intravascular catheter-related infection (CRI) ranges 
widely in the literature from 1% to 2% to greater than 25% (Eggimann et al. 
2004). It is estimated that approximately 250,000 cases of intravascular 
catheter-related bloodstream infections (CRBSI) occur yearly in the United 
States alone (Rogers et al. 2009). S. epidermidis is responsible for 50-70% of 
these infections (Huebner and Goldmann 1999). 
- Prosthetic valve endocarditis (PVE) and native valve endocarditis (NVE) are 
caused by CNS in 15-50% and 5-8% of cases, respectively. S. epidermidis is 
the most prominent cause of both PVE and NVE (Chu et al. 2008;Huebner 
and Goldmann 1999;Lalani et al. 2006;Rogers et al. 2009). 
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- CNS are the predominant pathogens causing 48% to 67% of cerebrospinal 
fluid shunt infections and S. epidermidis is the most common bacterial species 
isolated from these infections (Roos 1997). 
- Together with S. aureus, S. epidermidis ranks second as cause of surgical site 
infection (Rogers et al. 2009;Wilson et al. 1988). 
- CNS are responsible for two types of urinary tract infection (UTI): infections 
caused by S. saprophyticus, which affect young (18 to 35 years), sexually 
active women and young female outpatients; and UTIs due to mainly S. 
epidermidis, which occur equally in men and women (Huebner and Goldmann 
1999;Rogers et al. 2009). 
- CNS are currently responsible for more than 50% of all nosocomial infections 
in neonatal intensive care units (NICU). S. epidermidis is the most common 
isolate and has been implicated in 34% of cases of CRIs in children and 51% 
in neonates (Hira et al. 2007;Rogers et al. 2009). 
 Despite all these problems, Michael Otto in a recently published review paper in 
Nature Review Microbiology (Otto 2009) listed “evidences which indicated that most 
'virulence factors' of S. epidermidis originally had roles in the commensal lifestyle of this 
species” and drew the conclusion that “S. epidermidis should be regarded as an 
'accidental' pathogen, the clinical importance of which stems less from a dedicated 
infectious lifestyle and more from the frequency of contamination events and the 
existence of mechanisms, such as adhesion and immune evasion, that are beneficial for 
the bacteria during both colonization and chronic infection”. 
 
 
1.4. S. epidermidis device-related infections 
More than half a billion medical devices, ranging from simple catheters to total 
artificial hearts, are implanted in patients every year. An estimated 11 million people in 
the United States alone have medical implants, indicating the importance and value of 
implants. These devices, although helping millions of people to stay active, are prone to 
infection and prompt the bacteria to colonize. Colonization of foreign bodies by bacteria 
lead to serious local and systemic infections called foreign body infections (FBI). 
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Bacteria can contaminate a medical device during surgical implant insertion or through 
hematogenous seeding (Figure 1.1.). Once attached, bacteria start producing biofilm. 
 
 
  
 
Figure 1.1. Potential sources of catheter-related bloodstream infections. (http://www.phac-aspc.gc.ca/ 
publicat/ccdr-rmtc/97vol23/23s8/images/fig1inte.gif). HCW: Healthcare worker, Contam: contaminated 
 
 
A biofilm is defined as “a structured community of bacterial cells enclosed in a 
self-produced polymeric matrix and adherent to an inert or living surface” (Costerton et 
al. 1999). Biofilms are notoriously resistant to immune system attack and antimicrobial 
agents. They are a huge problem in medicine and industry, responsible for ≈65% of all 
bacterial infections (del Pozo and Patel 2007). 
S. epidermidis as a permanent and ubiquitous colonizer of human skin can easily 
contaminate devices during insertion. In fact, the success of S. epidermidis as a pathogen 
is mainly attributed to its ability to adhere to surfaces and form biofilm. The costs related 
to vascular CRBSIs alone caused by S. epidermidis amount to more than US$2 billion 
annually in the United States (Otto 2009;Rogers et al. 2009). S. epidermidis represents 
the most common source of infections on indwelling medical devices (Otto 2009). 
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1.5. S. epidermidis biofilm formation; switch from commensalism to 
pathogenicity 
Except for the rare infections such as osteomyelitis, endocarditis and wound 
infections in the absence of prostheses, CNS and, in particular S. epidermidis infections 
mostly occur in association with the use of medical devices. The ability to form biofilms 
on plastic devices is a major virulence factor for S. epidermidis (Raad et al. 1998). 
The development of a biofilm occurs in several steps. Biofilm formation starts 
with the initial adhesion of cells to a surface and their subsequent maturation phase. 
Detachment of cells or cell clusters from an existing biofilm can lead to the dissemination 
of the infection (Figure 1.2.). 
 
 
 
 
Figure 1.2. Schematic overview of the different stages of S. epidermidis biofilm formation (Otto 2009). 
PSMs: phenol-soluble modulins 
 
 
1.5.1. Primary attachment 
 Initial attachment can be based on direct binding to the abiotic surface of an 
implant. This process is mediated by hydrophobic interaction, van der Waals forces, 
electrostatic interaction between bacteria and implant surface, and several surface 
proteins, e.g. Ssp-1, Ssp-2, Bhp, and AtlE and teichoic acids (Gross et al. 2001;Heilmann 
et al. 1997;Tormo et al. 2005a;Veenstra et al. 1996). Alternatively, indirect binding to the 
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surface of implanted medical devices coated with host plasma and matrix proteins 
(conditioned material) such as fibrinogen (Fg), fibronectin (Fn), collagen (Cn), 
vitronectin (Vn) and elastin can be mediated via microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs) such as SdrG (Fbe), Embp, 
GehD, AtlE, and Ebps, respectively (Bowden et al. 2002;Davis et al. 2001;Heilmann et 
al. 1997;Nilsson et al. 1998;Park et al. 1996;Williams et al. 2002). 
 
1.5.2. Accumulation 
 Following adherence to the surfaces of implants, biofilms develop through 
intercellular aggregation that is mediated by intercellular adhesins. These include surface 
macromolecules such as exopolysaccharide, surface proteins, teichoic acids and 
extracellular DNA originating from lysed cells which are involved in formation of 
extracellular biofilm matrix. 
In Staphylococcus spp., production of polysaccharide intercellular adhesin [PIA, 
also called poly-N-acetylglucosamine (PNAG)] by the genes in the intercellular adhesion 
(ica) operon, is currently the best-understood mechanism [ica or PIA-dependent 
mechanism (Figure 1.3.a.)] of biofilm formation (Cramton et al. 1999;Gerke et al. 
1998;Mack et al. 1996). Recent studies have shown that there is a proteinaceous 
mechanism of biofilm formation (Figure 1.3.b.) which is independent of ica or PIA 
(Fitzpatrick et al. 2005;Hennig et al. 2007;Rohde et al. 2005). 
PIA is a homoglycan composed of β-1, 6-linked N-acetylglucosamine residues 
containing 15 to 20% de-N-acetylated amino groups and positively charged (Figure 1.4.). 
These positive charges have been shown to be of major biological importance in biofilm 
formation, virulence, and immune evasion (Vuong et al. 2004b). 
The icaADBC operon was identified by Tn917 transposon mutagenesis of S. 
epidermidis and screening for strains deficient in biofilm formation. This operon 
comprises 4 genes: icaA, icaD, icaB, and icaC (Figure 1.5.). The icaA gene product is a 
transmembrane protein which has N-acetylglucosaminyltransferase activity with UDP-N-
acetylglucosamine as a substrate. IcaA adds N-acetylglucosamine from UDP-N-
acetylglucosamine to the growing PIA chain, requiring the icaD gene product for optimal 
activity. N-acetylglucosamine oligomers produced by IcaAD reach a maximal length of 
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20 residues. Only when icaAD is coexpressed with icaC, longer oligomer chains are 
synthesized. The icaC gene product is a putative membrane protein, which is 
hypothetically involved in externalisation and elongation of the growing polysaccharide 
and is essential for the synthesis of full-length PIA. The icaB gene product is a surface-
attached protein responsible for deacetylation of the poly-N-acetylglucosamine molecule. 
Non-deacetylated poly-acetylglucosamine in an isogenic icaB mutant strain, most likely 
due to the loss of its cationic character cannot attach to the bacterial cell surface or 
mediate biofilm development. 
The divergently transcribed icaR gene, which is located upstream of the icaA 
gene, encodes a transcriptional repressor which appears to be a member of the TetR 
family of transcriptional regulators and negatively regulates icaADBC expression. 
In cases of PIA-independent biofilm formation, adhesive proteins have been 
suggested to be involved in the accumulation phase. In some strains (ica-positive or 
negative), biofilm formation is mediated by specific surface proteins such as 
accumulation-associated protein (Aap), biofilm-associated protein (Bap), or Bap 
homologue (Bhp) (Cucarella et al. 2001;Fitzpatrick et al. 2005;Hennig et al. 
2007;Hussain et al. 1997;Lasa and Penades 2006;Tormo et al. 2005a). 
 
1.5.3. Biofilm detachment 
 Once a mature biofilm has been established, cells or cell aggregates may be 
continuously released into the flowing extracellular fluid (bloodstream) on a chronic 
basis, with consequent bacteraemia as well as seeding to distant sites. In contrast to 
primary attachment and accumulation, detachment is poorly understood in 
Staphylococcus spp. However, several factors have been proposed to be involved in 
biofilm detachment including; mechanical forces (flow effect), changes in nutrient 
concentration, cessation of production of biofilm building material, and production of 
detachment factors which is mainly controlled by quorum-sensing (QS) system 
accessory-gene regulator (agr) (Otto 2008a;Otto 2009;Yao et al. 2005a). The detachment 
factors have been proposed to function via two detachment mechanisms (Figure 1.2.); 
enzymatic degradation of biofilm exopolymers (Boles and Horswill 2008) and disruption 
of non-covalent interactions by detergent-like molecules (Vuong et al. 2004a). Examples 
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Figure 1.3. Model of ica-dependent (a) and ica-independent (b) biofilm mechanisms in Staphylococcus 
spp. (O'Gara 2007). The green and red arrows indicate positive and negative regulatory pathways, 
respectively. 
Proteolytic 
conversion Unknown 
Unknown 
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Figure 1.4. Structure of polysaccharide intercellular adhesin (PIA), a linear homoglycan composed of β-1, 
6-linked N-acetylglucosamine residues (Gotz 2002). 
 
 
  
 
Figure 1.5. Schematic overview of PIA synthesis (a) and the gene arrangement in the ica operon (b) (Otto 
2009). 
 
 
of such factors in S. epidermidis are the short amphipathic phenol-soluble modulins 
(PSMs) and delta-toxin. In Pseudomonas aeruginosa a degrading enzyme (phosphatase) 
is encoded by the genetic locus that encodes the phosphate kinase responsible for the 
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production of the biofilm factor polyphosphate (Rashid et al. 2000). The same locus in S. 
epidermidis shows the same organization. However, the ica locus does not encode a 
protein to which a PIA-degrading activity could be attributed by similarity. 
 
 
1.6. Regulation of biofilm formation 
S. epidermidis possesses several regulator systems including agr, luxS, 
staphylococcal accessory regulator sarA, sae, and the alternative sigma factor σB which 
regulate biofilm formation in response to environmental conditions (Figure 1.6.). Until 
recently, many researchers have equated the staphylococcal biofilm matrix with PIA, 
which as we now know is not completely valid. Hence, the regulation of PIA expression 
is the best studied among the regulatory influences on staphylococcal biofilm formation. 
The regulators, for which a mechanism for their influence on biofilm formation has been 
described, are discussed below. 
 
1.6.1. Quorum sensing systems 
 The QS systems are global regulators that control gene expression in response to 
cell density by small signaling molecules. The signal molecules of QS systems are small 
molecules called autoinducers (AIs). So far, three different types of AIs have been 
described: N-acylhomoserine lactones (HSL, AI-1) produced by Gram-negative bacteria, 
LuxS/autoinducer-2 (AI-2) common to Gram-positive as well as Gram-negative 
organisms, and oligopeptides produced from pre-proteins occurring in many Gram-
positive bacterial species (Mack et al. 2007). The accumulation of high concentrations of 
AIs due to the increase in cell population density activates QS systems which in turn 
regulate the expression of various genes. In S. epidermidis two QS systems have been 
described to date: the agr system (Kong et al. 2006) and luxS/AI-2 system (Li et al. 
2008;Xu et al. 2006). Both QS systems appear to repress the formation of biofilm. 
 
1.6.1.1. agr 
 The agr locus consists of two divergent promoters, P2 and P3, the P2 transcript 
covers 4 genes (agrA, agrC, agrD and agrB) that are co-transcribed (Figure 1.7.). The  
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Figure 1.6. Schematic overview of the regulation of biofilm formation in S. epidermidis (Mack et al. 2007). 
Rectangles represent genes, ovals represent proteins. 
 
 
agrB and agrD gene products are engaged in the production of the AI which is a short 
peptide (7 to 9 amino acids in length). The AI is encoded within the agrD gene as a larger 
polypeptide, and subsequently trimmed by the agrB gene product to form a thiolactone-
containing ring structure. The agrA and agrC gene products constitute a classical two-
component signaling transduction system. At the threshold concentration of the 
autoinducer peptide (AIP), the AIP is bound by AgrC, which is a membrane-bound 
receptor. AgrC phosphorylates AgrA and activates it. AgrA activates the P2 and P3 
promoters. The P2 promoter controls expression of agrB, agrD, agrC and agrA, thereby 
closing the quorum sensing circuit, whereas activation of P3 promoter drives expression 
of the effector molecule RNAIII, which in turn controls transcription of the target genes 
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by a mechanism of which the details are still unknown. One possibility is that RNAIII 
acts via trans-acting factors, as RNAIII is potentially capable of forming a stable 
secondary structure that may create protein binding sites. RNAIII expression upregulates 
the expression of exoproteins including PSMs which play a role in detachment, and 
downregulates expression of surface proteins such as AtlE and other MSCRAMMs which 
play roles in attachment and binding to host matrix proteins. 
 
 
  
 
Figure 1.7. Schematic overview of agr QS system in S. epidermidis (Novick and Geisinger 2008). 
 
 
In a biofilm, agr expression is limited to bacteria in the surface-exposed area and 
probably regulates biofilm detachment by upregulation of PSM effector molecules. 
Furthermore, agr mutants occur naturally in deeper layers of biofilm at a relatively high 
rate. 
Due to sequence variation in the sequence of agr genes (agrB, C, D) AIs from 
different S. aureus and S. epidermidis strains can be divided into 4 different classes 
named I to IV, in which AIP produced by one group inhibits agr expression in other 
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groups (Otto et al. 2001). Because of this cross-inhibition phenomenon, it is speculated 
that staphylococcal biofilms are single species or even single strain biofilms instead of 
mixed-strain biofilms and the agr pheromones and system have been suggested as a 
target for the development of anti-staphylococcal therapeutics (Balaban et al. 
2003;Balaban et al. 2007). However, recent studies demonstrated that agr dysfunction or 
blocking of the quorum-sensing increased biofilm formation and persistence of an 
infection (Otto 2004a;Vuong et al. 2000). 
 
1.6.1.2. luxS 
 The other QS system in S. epidermidis that has a significant impact on biofilm 
development is the luxS/AI-2 system. AI-2 which is supposed to be designed for 
interspecies communication is synthesized by the luxS gene. AI-2 is mainly expressed 
during the logarithmic growth phase and its expression is reduced in the stationary 
growth phase in S. epidermidis. It has been demonstrated that AI-2 via a signaling 
function, influences biofilm formation in vitro and enhances virulence in a rat model of 
biofilm-associated infection. This is most likely due to regulation of ica operon genes and 
PIA production and its control of expression of PSMs. However, in contrast to the agr 
system, the details of the mechanism of the AI-2 signaling function and the sensors or 
transporters for AI-2 in S. epidermidis are not yet known. The regulatory effect of luxS on 
expression of ica operon genes couldn’t be confirmed in another study by the same 
research group (Li et al. 2008). 
 
1.6.2. Alternative sigma factor B 
Bacterial RNA polymerase enzymes require a specialized subunit called sigma 
factor (σ) to recognize and contact their promoter. Three sigma factors (σA, σB, σH) have 
been identified in Staphylococcus spp., among which σB has been intensively studied 
(Kies et al. 2001). In S. epidermidis the σB operon consists of four genes, rsbU, rsbV, 
rsbW and sigB, among which rsbU is preceded by a SigA-dependent promoter, whereas a 
SigB-dependent promoter precedes the last three genes. SigB increases its own 
transcription as a consequence of its activation, further inducing the entire σB regulon. 
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Activity of sigma factors is increased in response to specific signals or stress conditions 
(Figure 1.6.). 
SigB activity is regulated by a regulatory cascade including the anti-sigma factor 
RsbW (negative regulator), the anti-anti-sigma factor RsbV and the RsbV-specific 
phosphatase RsbU (positive regulators). RsbW is the key negative regulator of SigB and 
inactivates it by binding to it. RsbV, in its dephosphorylated form, modulated by RsbU 
under stress conditions via specific signals can bind competitively to RsbW, resulting in 
release of free and active SigB (Knobloch et al. 2001). 
The influence of σB on biofilm formation appears to occur via repression of icaR 
transcription, which in turn represses transcription of icaADBC (Knobloch et al. 2004). 
However, it has been recently demonstrated that σB is less important for biofilms under 
high-oxygen conditions than under low-oxygen conditions and the regulation of ica 
operon expression and biofilm development in S. epidermidis and S. aureus is different. 
Unlike in S. epidermidis, mutations in the S. aureus sigB locus do not result in a biofilm 
negative phenotype (Cotter et al. 2009). 
 
1.6.3. sarA 
 The staphylococcal accessory regulator locus sarA encodes a DNA-binding 
protein that is involved in the regulation of the biofilm formation in S. epidermidis by 
affecting ica operon transcription in an IcaR-independent manner or by interfering with 
PIA production at a later stage (Figure 1.3. & 1.6.) (Tao et al. 2006;Tormo et al. 2005b). 
The regulatory pathways influencing biofilm formation dependent on SarA and SigB are 
different, although these pathways are interconnected as one of the three sarA promoters 
is SigB-dependent. 
 
1.6.4. Other regulators 
Several other regulatory gene loci, which influence the biofilm formation process 
in S. epidermidis have been identified by transposon Tn917 insertional mutagenesis or 
phase variation of biofilm formation (Conlon et al. 2004;Heilmann et al. 1996;Heilmann 
and Gotz 1998) but their mechanism of action and their functions are still unknown. 
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1.6.5. Environmental factors 
It has been shown that S. epidermidis biofilm formation in vitro can be influenced 
by environmental factors such as, oxygen (O2), glucose, iron (Fe), salt, ethanol, antibiotic 
stress, Mg2+, temperature and EDTA which may act through regulatory proteins like Agr, 
σB and the intercellular adhesion regulator, IcaR. 
The icaADBC operon is activated in a SigB-independent, IcaR-dependent manner 
by ethanol (Knobloch et al. 2001). Induction of biofilm formation by addition of glucose 
is IcaR-, icaADBC-independent and is suggested to depend on the continuous translation 
of a so far unidentified glucose-regulated protein (Conlon et al. 2004;Dobinsky et al. 
2003). The icaADBC operon is activated in a SigmaB-, IcaR-independent manner by 
sodium chloride (NaCl) (Conlon et al. 2004). In S. aureus, the rbf (regulator of biofilm 
formation) gene, regulates biofilm development in media supplemented with glucose or 
NaCl (Lim et al. 2004). 
 
 
1.7. Prevention and treatment of S. epidermidis biofilm-associated 
infections 
Currently, the only completely effective method for curing biofilm infections is to 
remove the infected device, a risky, costly and stressful procedure. Biofilms act as a 
shield that protects the bacterial cells from harsh environmental conditions such as UV 
exposure, metal toxicity, acid exposure, dehydration and salinity, phagocytosis and 
antibiotics or other antimicrobial agents (Hall-Stoodley et al. 2004). The central problem 
with microbial biofilm infections is their propensity to resist clearance by the host 
immune system and all antimicrobial agents tested to date. In fact, compared to their free 
floating (planktonic) counterparts, bacteria within a biofilm (sessile) are up to a 1000 
times more resistant to antimicrobial agents (Stewart and Costerton 2001). Factors that 
contribute to the general resistance of biofilms are; 
- Restricted penetration of antimicrobial compounds. 
- Decreased growth rate of bacteria in a biofilm making them less susceptible to 
antimicrobials targeting metabolic pathways. 
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- A distinct phenotype that confers resistance to antimicrobials and the host 
immune defence and facilitates horizontal gene transfer. 
- The presence of persister cells. Persisters are a unique class of inactive but 
highly protected cells that withstand a wide range of antimicrobial agents. 
Different strategies, used to combat the biofilm infections have been summarized 
in table 1.1. The preventive strategies target functional molecules, gene systems and 
regulatory circuits, which control early stages of biofilm development, before 
establishment of a mature biofilm. Therapeutic strategies are aimed at the disintegration 
of established biofilms and include QS perturbation, which leads to the downregulation of 
molecules stabilising the biofilm architecture, or the use of enzymes to dissolve the 
biofilm matrix (Speziale et al. 2008). 
 Another frequently utilized option involves modification of biomaterial surface to 
overcome bacterial colonization and development of biomaterial capable of exerting 
antimicrobial action. This strategy is based on the prophylactic use of antibiotics and 
includes immersion, coating and matrix loading, preventing microbial contamination 
from occurring on the surface of the medical device in the first instance and therefore 
preventing bacterial colonisation and biofilm formation. The problem with this method is 
the selection of resistance. 
 Immunoprophylaxis and immunotherapy targeting proteins and surface 
components that are expressed in vivo and are important for biofilm formation are 
promising new approaches to prevention and treatment of biofilms. Several recent studies 
have shown that application of antibodies against surface components of S. epidermidis 
can affect the rate of biofilm formation or adherence of bacteria to the medical devices in 
vitro. Cerca et al. showed that antibodies against PIA readily penetrated the biofilm and 
bound to the sessile cells (Cerca et al. 2006), although sessile bacteria exhibited more 
resistance to opsonic killing than their planktonic counterparts. Using polyclonal 
antibodies against a Fg-binding protein from S. epidermidis (Fbe), Pei et al. could block 
adherence of S. epidermidis to Fg-coated catheters in vitro (Pei and Flock 2001a). Sun et 
al. showed that monoclonal antibodies against Aap can significantly reduce the 
accumulation phase of biofilm formation by S. epidermidis in vitro (Sun et al. 2005). 
Maira-Litran et al. showed that vaccination of rats with purified PIA/PNAG can elicit  
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Table 1.1. Novel antibiofilm approaches (Mccann et al. 2008). 
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protective immunity against both CNS and S. aureus (Maira-Litran et al. 2004). 
However, recent studies have shown the existence of PIA-independent biofilm 
mechanisms in both S. epidermidis and S. aureus. 
A list of surface-expressed components of S. epidermidis as the potential targets 
for vaccine development including PIA, teichoic acids, proteinaceous adhesins and cell-
wall anchored proteins has been summarized by Götz (Gotz 2004). In a recent 
publication, Otto reviewed the potential use of surface components of Staphylococcus 
spp., with emphasis on MSCRAMMs as target for developing an anti-Staphylococcus 
spp. vaccine (Otto 2008b). 
Currently, most vaccines available for human use are whole (killed or attenuated) 
microorganisms or subunit vaccines, developed using conventional methods that follow 
the paradigm established by Pasteur over a century ago. However, S. epidermidis is a 
ubiquitous colonizer of human skin, and staphylococcal infections don’t cause immune 
protection in the long term. Accordingly, whole-cell vaccines generally do not achieve 
protection from S. epidermidis. 
In 2 different independent studies, immunogenic cell wall-associated proteins of 
S. epidermidis were experimentally identified (Pourmand et al. 2006;Sellman et al. 
2005). However, the potential use of these targets for vaccination or immunotherapy 
against S. epidermidis biofilms in FBI has not been investigated. 
Conventional vaccinology is time-consuming and inadequate in the development 
of vaccines for those pathogens that are antigenically diverse or cannot be cultivated in 
the laboratory. Recently, there have been two revolutions in vaccine design; i) use of 
modern recombinant DNA technology to produce subunit vaccines, ii) using whole-
genome sequences and bioinformatics termed ‘reverse vaccinology’ (Mora et al. 2003) to 
identify potential vaccine targets. Reverse vaccinology doesn’t have the limitations of 
conventional vaccinology, and vaccine candidates can be rapidly identified in silico 
before being subjected to confirmatory studies. However, non-protein antigens (e.g. 
polysaccharides, lipopolysaccharides and glycolipids) can’t be studied using this method. 
The first step in reverse vaccinology is identification of the complete repertoire of 
antigens that are expressed on the surface. The identification of potential antigens can be 
done using 3 different approaches; i) proteomics (Sellman et al. 2005), ii) immunomics 
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(Pourmand et al. 2006), iii) in silico analysis (this study), followed by high-throughput 
expression and screening of vaccine candidates. Vaccine development proceeds by 
epitope mapping and quantification and qualification of immune response to the used 
epitopes. 
An advantage of immunotherapeutic methods is the lesser risk for the 
development of resistance. However, S. epidermidis has certain features including the 
occurrence of allelic variation, redundant protein functions or altered stress-induced 
expression properties that make the development of a vaccine difficult. S. epidermidis is 
also a common part of the human microflora and eradication of S. epidermidis may lead 
to severe disturbances of the physiological balance on human epithelia and allow 
potentially more harmful microorganisms to take its place. In addition, animal protection 
models, in contrast to humans, have only limited value for anti-staphylococcal vaccine 
development. Thus, only at the stage of clinical trials can the efficacy of an anti-
staphylococcal vaccine be evaluated, as two high-profile vaccine preparations have failed 
clinical trials within the last few years (Otto 2008b). 
 
 
1.8. Aims and general outline of this work  
The aims of this work were as follows:  
1. To identify potential target(s) for vaccines against S. epidermidis 
biofilms. 
2. To establish the protective effect of antibodies against the selected 
target(s) in prevention and treatment of FBI in ‘in vitro’ and ‘in vivo’ 
models. 
3. To establish the protective effect of immunization with the selected 
target(s) on ‘in vivo’ FBI. 
4. To investigate the role(s) of the selected target(s) in S. epidermidis 
biofilm formation. 
The general outline of this work is as follows: 
First, genes coding for S. epidermidis ‘surface-exposed proteins’ [Ses; 
terminology used previously by Gill et al. and Bowden et al. (Bowden et al. 2005;Gill et 
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al. 2005)] were identified by an in silico procedure. From these, 13 proteins were selected 
based on protein size, number of antigenic determinants and the role in S. epidermidis 
biofilm formation and pathogenesis of the protein family to which the candidate protein 
belongs. 
The presence of these 13 genes in S. epidermidis clinical isolates was investigated 
and - using previously described in vitro and in vivo rat models for FBI (Vandecasteele et 
al. 2001;Vandecasteele et al. 2002) - the expression of these 13 genes was investigated in 
planktonic and sessile bacteria during FBI. 
For the biofilm inhibition studies, extracellular coding regions of 5 out of the 13 
genes were cloned, recombinantly expressed and purified. Rabbit hyperimmune sera 
against these 5 recombinant proteins were raised and the total IgG fraction from pre- and 
hyperimmune sera was isolated. The effect of pre- and post-immune IgGs on primary 
attachment and accumulation phases of S. epidermidis biofilm formation was tested in 
vitro (Christensen et al. 1985;Sun et al. 2005). 
Finally, SesC, against which antibodies exhibited the highest inhibition of biofilm 
formation in vitro was selected for further investigation. The effect of different 
concentrations of purified specific anti-SesC IgGs (αSesC-IgGs) was tested in vitro on 
primary attachment, overnight biofilm formation and established (1-day old) biofilms of 
different S. epidermidis strains. We also tested the effect of αSesC-IgGs on established 
biofilms of S. epidermidis in our in vivo rat model for FBI. Finally, rats were immunized 
with SesC and the effect of immunization on FBI was evaluated. 
To unravel the structure and function of SesC, different bioinformatics tools were 
used and we studied the effect of expression of sesC in the sesC-negative strain S. aureus 
RN4220 (Kreiswirth et al. 1983). 
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2. Identification of Ses proteins of S. epidermidis 
 
 
2.1. Introduction 
The first step in reverse vaccinology is in silico selection of potential antigens for 
vaccine development. The success of reverse vaccinology-based strategies is dependent 
on the criteria used in this in silico procedure. The surface components, in particular those 
surface proteins which are highly expressed in the blood stream and in biofilms, with a 
possible role in biofilm formation, are hypothesized to be the best antigens for 
development of a vaccine against biofilms (Otto 2008b). 
Out of 57 identified Ses proteins using the in silico procedure, 13 proteins were 
selected for further investigation, based on the protein size, the number of antigenic 
determinants and the importance of the protein family, to which the candidate protein 
belongs, in S. epidermidis biofilm formation and pathogenesis. 
 
 
2.2. Materials and methods 
 
2.2.1. In silico selection of Ses proteins 
The complete sequence of S. epidermidis ATCC 12228 (Zhang et al. 2003) was 
retrieved from the National Centre of Biotechnology Information (NCBI) GenBank 
(http://www.ncbi.nlm.nih.gov/Genbank/). We predicted the presence of a signal peptide 
at the N-terminus, using the SignalP server (http://www.cbs.dtu.dk/services/SignalP-2.0/). 
Thereafter, we predicted the number of transmembrane (TM) domains in proteins with a 
signal peptide, using the TMHMM server (http://www.cbs.dtu.dk/services/TMHMM-
2.0/). Finally, we performed a retention domain prediction on the proteins with none or a 
single transmembrane domain, searching for lipobox motifs, peptidoglycan binding 
domains (PBD), choline binding domains (CBD) and LPXTG motifs. Proteins with two 
transmembrane domains were analyzed for LPXTG motifs as well. Retention domains 
were predicted using the PATTINPROT server (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=/NPSA/npsa_uploadfile.html). The prediction of protein 
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subcellular localization was reanalysed using the online tool PSORTb V.2.0.4 
(http://www.psort.org/psortb/). The sequences of all identified Ses proteins were 
subjected to antigenicity analysis using the ‘Predicting Antigenic Peptides’ server 
(http://imed.med.ucm.es/Tools/antigenic.pl). 
 
2.2.2. Gene identification 
The sequences of selected ses genes were retrieved via the NCBI GenBank from 
the complete genome of the non-biofilm forming S. epidermidis strain ATCC 12228. All 
selected genes were subsequently sequenced in S. epidermidis strain 10b (Van 
Wijngaerden et al. 1999). The 10b strain is a strong biofilm-forming S. epidermidis, 
which was isolated from a patient with a proven CRI. On the basis of these sequences, all 
primers and probes were designed with Primer Express 2.0 software (Applied Biosystems 
Division of Perkin-Elmer) and were purchased from Eurogentec (Seraing, Belgium). In 
this study all fragments were PCR amplified using genomic DNA (gDNA) isolated from 
S. epidermidis strain 10b, unless otherwise specified. 
 
2.2.3. Bacterial isolates and species identification 
A total of 76 S. epidermidis clinical and commensal isolates from hospitalised 
patients (n = 60), skin of healthy individuals (n = 11) in our department and five 
previously described strains {10b, 1457 (Mack et al. 1992), ATCC 35984 [RP62A (Gill 
et al. 2005)], ATCC 12228 and TU3298 (Allgaier et al. 1985)} were collected. Clinical 
isolates were recovered from blood cultures of neonates (n = 45) with late-onset sepsis 
and an intravascular catheter in place at the NICU of the Erasmus MC–Sophia Children's 
Hospital in Rotterdam, (the Netherlands) and from different clinical specimens from 
patients (n = 15) hospitalized at the University Hospital Gasthuisberg (Katholieke 
Universiteit Leuven) in Leuven, Belgium. Species identification was with VITEK 2 
(bioMérieux). 
 
2.2.4. PCR screening of ses genes in clinical and commensal isolates 
We performed a duplex PCR, amplifying both a ses gene and the 16S ribosomal 
RNA (16S rRNA) gene. The primers used for amplification of the ses genes are listed in 
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table 2.1., and primers for the 16S ribosome gene were previously described 
(Vandecasteele et al. 2001). For each strain, genomic DNA was extracted using a 
QIAamp DNA mini kit (Qiagen). 
 
 
Table 2.1. List of primers used in PCR screening of ses genes in clinical and commensal isolates and for 
cloning in the pGEM-T Easy vector used as standard in real time PCR (Chapter 3.2.2.). 
 
 
Locus Name 
 
Forward primer 5’… 3’ 
 
Reverse primer 5’… 3’ 
 
Fragment length 
 
SE0193 CCCGTAGCTAAGAAAATCGC 
 
GGCTTGGTTCTTCCGCATTC 469 
 
SE0331 CCTCATCAGTCGAATCCTC 
 
CAGCATCATGTGCTTTAAT 477 
 
SE0684 CTGCCGATACACCGGATGG 
 
GCGTCGTTTCAGGCCCTAC 579 
 
SE0828 TCAACCATCAGCACCTGGAA 
 
TGATCACCAGTGGCACCTTG 423 
 
SE1106 TGGGCCACTCAATACAGTCA 
 
TTGGCGTGTTTCTGTCTTTG 435 
 
SE1500 CTGGGTTGACCAAACTTGGC 
 
GGTTTTTCTCCAATAAAGCCA 378 
 
SE1501 CCAATTACTAGTATTAAATTCAG 
 
CTACACTGTTAGACGTGAG 355 
 
SE1588 GGTACTACGGTTGAAGAGGG 
 
TTGTGGTTCTTTATCGTCTTTAG 390 
 
SE1981 CAGGTGCCTTGGAATCGC 
 
GCGTACCTTGCCAGTAGTC 441 
 
SE2152 GCTATGAAAAATAGTGGTGGC 
 
CGTAGTATGAATTGAGCTCAC 298 
 
SE2212 GAAAGCCAAACAACAAAGTGA 
 
CCACTTCACATCTTGAACTTG 325 
 
SE2232 GTTGATAACCGTCAACAAGG 
 
CATGTTGATCTTTTGAATCCC 388 
 
SE2395 GACAGCATAAAAGAGGGAG 
 
CCGTCACTTCGTAAACTTTCAC 499 
 
 
2.3. Results 
 
2.3.1. Selection of Ses proteins 
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 Figure 2.1. shows a diagram of our in silico selection procedure. In total, 57 
proteins have been identified as Ses proteins of which 32 were annotated as (conserved) 
hypothetical (data not shown). Seven LPXTG-containing proteins and 6 lipobox-
containing proteins were selected for further investigation (Table 2.2.). Out of 13 selected 
proteins, 5 proteins of which the function had not yet been characterized, were selected to 
investigate their potential use as a target for biofilm inhibition (marked by * in table 2.2.). 
 
 
 
 
Figure 2.1. In silico selection of genes coding for Ses proteins of S. epidermidis. 
 
 
2.3.2. Presence of ses genes in clinical and commensal isolates 
 Presence of ses genes in clinical and commensal isolates of S. epidermidis is listed 
in table 2.3. There was no significant difference for the prevalence of genes in clinical or 
commensal isolates. 
 
 
2.4. Discussion 
 Four major types of cell surface proteins in Gram-positive bacteria are: (i) 
transmembrane proteins, (ii) lipoproteins, (iii) LPXTG-like proteins and (iv) cell wall 
binding proteins (Desvaux et al. 2006;Scott and Barnett 2006). Five LPXTG motif 
containing proteins (Aap, Bhp, SdrF, SdrG and SesI) are known to play important roles in  
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Table 2.2. List of selected Ses proteins by in silico procedure used in this study. No. of AD: number of 
antigenic determinants, *: selected for biofilm inhibition studies, aa: amino acid 
 
 
Locus 
Name 
 
Putative product name 
 
Protein accession 
number 
 
Protein size 
(aa) 
 
Motif 
 
No. of 
AD 
 
SE2395 
 
Ser-Asp rich fibrinogen-binding,bone 
sialoprotein-binding protein (SdrF) 
 
NP_765950.1 
 
1633 
 
LPXTG 
 
50 
 
SE0331 
 
Ser-Asp rich fibrinogen-binding, bone 
sialoprotein-binding protein (SdrG) 
 
NP_763886.1 
 
1056 
 
LPXTG 
 
29 
 
SE1500 
 
hypothetical protein (SesJ) 
 
NP_765055.1 
 
1012 
 
LPXTG 
 
40 
 
SE0828 
 
lipoprotein VsaC (SesE) 
 
NP_764383.1 
 
827 
 
LPXTG 
 
31 
 
SE2232 * 
 
conserved hypothetical protein (SesC) 
 
NP_765787.1 
 
676 
 
LPXTG 
 
20 
 
SE1106 * 
 
ABC transporter _membrane spanning protein 
 
NP_764661.1 
 
564 
 
Lipobox 
 
16 
 
SE0684 
 
peptide binding protein OppA 
 
NP_764239.1 
 
547 
 
Lipobox 
 
19 
 
SE1981 * 
 
nickel ABC transporter nickel-binding protein 
 
NP_765536.1 
 
491 
 
Lipobox 
 
18 
 
SE1501 * 
 
hypothetical protein (SesK) 
 
NP_765056.1 
 
415 
 
LPXTG 
 
11 
 
SE1588 
 
conserved hypothetical protein 
 
NP_765143.1 
 
402 
 
Lipobox 
 
13 
 
SE2212 
 
conserved hypothetical protein 
 
NP_765767.1 
 
388 
 
Lipobox 
 
16 
 
SE0193 
 
Zn-binding lipoprotein adcA 
 
NP_763748.1 
 
331 
 
Lipobox 
 
11 
 
SE2152 * 
 
hypothetical protein (SesB) 
 
NP_765707.1 
 
196 
 
LPXTG 
 
7 
 
 
the pathogenesis of S. epidermidis infections (Arrecubieta et al. 2007;Cucarella et al. 
2001;Davis et al. 2001;Hussain et al. 1997;Soderquist 2007). In publicly available 
genomes of S. epidermidis strains RP62A and ATCC12228, respectively 11 and 10 genes 
encoding LPXTG proteins have been identified (Bowden et al. 2005) including those 
already mentioned. Except for the 5 LPXTG proteins mentioned above, the role of these 
LPXTG proteins has not been studied yet. 
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Table 2.3. List of the selected ses genes and their distribution among S. epidermidis isolates. The values 
show the number of isolates positive for the gene as a proportion of the total number of isolates tested. 
 
Locus 
Name 
 
Name used in other studies 
(Bowden et al. 2005;Gill et al. 2005) 
Name used in 
this study 
 
Presence in commensal 
isolates (n= 11 ) 
 
Presence in clinical 
isolates (n= 65 ) 
 
SE0193  sesN 
 
11/11 
 
63/65 
 
SE0331 sdrG  
 
11/11 
 
65/65 
 
SE0684  sesO 
 
11/11 
 
65/65 
 
SE0828 sesE  
 
11/11 
 
65/65 
 
SE1106  sesL 
 
7/11 
 
45/65 
 
SE1500 sesJ  
 
1/11 
 
3/65 
 
SE1501 sesK  
 
1/11 
 
6/65 
 
SE1588  sesP 
 
11/11 
 
64/65 
 
SE1981  sesM 
 
11/11 
 
65/65 
 
SE2152 sesB  
 
11/11 
 
65/65 
 
SE2212  sesQ 
 
11/11 
 
65/65 
 
SE2232 sesC  
 
11/11 
 
65/65 
 
SE2395 sdrF  
 
8/11 
 
57/65 
 
 
Lipoproteins can be involved in a large variety of physiological functions, i.e. 
adhesion, transport, receptors, enzymes or virulence factors (Sutcliffe and Russell 1995). 
ABC transporter systems belong to a family of proteins which in Gram-positive bacteria 
performs important roles as substrate-binding proteins, in antibiotic resistance, in cell 
signaling, in protein export and folding, in sporulation and germination, in conjugation, in 
biofilm formation and various other functions (Sutcliffe and Harrington 2002). 
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Hence, based on protein length, conserved domains, and the number of antigenic 
determinants, 7 LPXTG-motif containing proteins and 6 proteins with the longest amino 
acid sequences and a high number of antigenic determinants were selected for further 
analysis. All of the selected proteins are predicted to be located on the cell surface of S. 
epidermidis. For some of these proteins, a tentative role in adherence to host or foreign 
bodies has already been proposed. 
SE0193 (Zn-binding lipoprotein AdcA) is a homologue of a gene product in the 
adcCBA operon in Streptococcus gordonii that plays an important role in biofilm 
formation of this species (Mitrakul et al. 2005). Upregulation of this gene has been 
documented in S. epidermidis biofilms by microarray analysis (Yao et al. 2005a), but its 
precise role in S. epidermidis biofilm formation is still unknown. 
SE0331 or Fbe (Ser-Asp rich Fg-binding, bone sialoprotein-binding protein or 
SdrG), is a major factor in adherence of S. epidermidis to Fg-coated surfaces (Pei and 
Flock 2001b). It was demonstrated that antibodies against Fbe can block adherence of S. 
epidermidis to Fg-coated surfaces (Pei and Flock 2001a). 
SE0193, SE0684, SE1106, SE1981 proteins are members of the ABC transporter 
family. SE1500, SE1501, SE1588, SE1981, SE2152, SE2212 and SE2232 are 
hypothetical proteins for which no information is available so far that links them to 
biofilm formation. SE0331, SE0828, SE1500, SE1501, SE2152, SE2232, SE2395 belong 
to the LPXTG protein family. 
SE0828 (lipoprotein VsaC) is a homologue of the VsaC protein of Mycoplasma 
pulmonis which is a variable surface lipoprotein antigen. Proteins encoded by this locus 
are important in strong adherence to polystyrene and erythrocytes and resistance to 
complement (Simmons et al. 2004). 
SE2395 or SdrF (Ser-Asp rich Fg-binding, bone sialoprotein-binding protein), is a 
member of Sdr proteins. The SdrF, SdrG and SdrH proteins are cell-wall associated 
proteins that specifically bind host proteins and which all have a highly conserved motif 
of which the consensus sequence is TYTFTDYVD. Sdrf is a Cn-binding MSCRAMM 
(Arrecubieta et al. 2007). 
 
 
 CHAPTER 2: IDENTIFICATION OF SES PROTEINS OF S. EPIDERMIDIS  
 
 
 51
2.5. Conclusion 
The presence of proteins previously identified as surface proteins among the list 
of proteins identified as Ses proteins by our in silico procedure confirms the reliability of 
our method. However, further investigation is needed to validate the presence and 
expression of the selected proteins on the surface of S. epidermidis. The presence of some 
of the selected ses genes in all tested isolates might be linked to an essential function of 
the gene in S. epidermidis. 
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3. In vitro and in vivo gene expression studies 
 
This chapter is based on the following reference: Mohammad Shahrooei, Vishal Hira, Rita Merckx, Benoit 
Stijlmans, Peter W.M. Hermans, Johan Van Eldere. 2009. Inhibition of Staphylococcus epidermidis biofilm formation 
by rabbit polyclonal antibodies against SesC protein. Infection and Immunity. 77(9):3670-8. 
 
 
3.1 Introduction 
After the in silico selection of potential vaccine antigens, the next step was to 
validate them by identification of their expression in vitro and in vivo. However, since 
biofilm cells show altered gene expression patterns compared to their planktonic 
counterparts (Vandecasteele et al. 2003;Vandecasteele et al. 2004;Yao et al. 2005b;Yao 
et al. 2005a), expression of the candidate genes in biofilm cells must specifically be 
investigated. 
A technique for direct quantification of bacterial transcripts during in vitro and in 
vivo FBI based on quantitative PCR has been developed by Vandecasteele et al. 
(Vandecasteele et al. 2001;Vandecasteele et al. 2002). This methodology has been 
previously used to document the time-dependent induction in vitro and in vivo of 
structural biofilm genes, such as ica operon genes, aap, mecA, and 16S rRNA gene as a 
determinant of metabolic activity (Vandecasteele et al. 2003;Vandecasteele et al. 2004). 
Using this method, expression of iron-responsive genes such as sirR and the sit operon 
and global regulator genes such as sarA, sigB, and agr during the time course of biofilm 
development in vitro and in vivo was investigated (Massonet et al. 2006;Pintens et al. 
2008). 
 
 
3.2. Materials and methods 
 
3.2.1. Bacterial strains and growth conditions 
For all experiments, unless specifically mentioned, a previously described clinical 
S. epidermidis 10b strain was cultured in Brain Heart Infusion, (BHI, Oxoid). 
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3.2.2. Gene identification, cloning and quantification of copy number 
The sequences of selected 13 ses genes (Table 2.2.) were retrieved from the 
complete genome of the non-biofilm-forming S. epidermidis strain ATCC 12228 
(NC_004461) from NCBI GenBank. On the basis of these sequences, primers and probes 
were designed with Primer Express 2.0 software (Applied Biosystems Division of Perkin-
Elmer) and were purchased from Eurogentec (Seraing, Belgium). All primers and probes 
used in gene expression studies were listed in table 2.1. and 3.1. All fragments were PCR 
amplified using gDNA isolated from S. epidermidis strain 10b. PCR was performed on a 
GeneAmp PCR System 9700 (PE Applied Biosystems). 
The PCR-products of all genes amplified using primers listed in table 2.1. were 
cloned in the pGEM-T Easy vector system (Promega) according to the instructions of the 
manufacturer. Pure plasmids DNA were isolated using the High Pure Plasmid Isolation 
Kit (Roche Diagnostics), sequenced on the ABI 310 (PE Applied Biosystems) according 
to the manufacturer's instructions, and quantified with the Genequant RNA/DNA 
calculator (Amersham Pharmacia Biotech). 
 
3.2.3. Model for gene expression in planktonic and sessile bacteria in vitro  
For in vitro studies, 20 µl of a frozen culture of S. epidermidis 10b was inoculated 
in 5 ml fresh BHI and incubated at 37°C in a shaking incubator at 250 rpm. Bacteria were 
grown to the end-exponential growth phase, pelleted, and resuspended in 0.9% NaCl. 
Seven mm fragments of a commercial polyurethane intravenous catheter (Arrow 
International, Reading, Pa.) were added and the mixture was incubated at 37°C. After 
varying incubation periods (0, 10, 35, 60, 120, and 180 min), 16 samples, from 2 
independent experiments, were taken for DNA and RNA extraction, from both planktonic 
and sessile bacteria. 
 
3.2.4. Rat model for in vivo foreign body infection 
For the in vivo rat model, first-generation descendants of inbred germfree Fisher 
rats were used. This rat strain was inbred and maintained under germ-free conditions in 
the Rega Institute, University of Leuven, since 1965 (Van Wijngaerden et al. 1999). The 
rats were exposed to normal rat flora from birth and were labeled ‘ex-germfree Fisher rats 
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(EGF)’. All animal experiments were conducted in compliance with the guidelines for 
animal experimentation. 
Seven mm long catheter fragments were inoculated with a low inoculum of S. 
epidermidis 10b (104 cells/catheter) prior to implantation by incubation for 20 min at 
37°C in a 0.9% NaCl suspension of S. epidermidis 10b. This resulted in a 100% infection 
rate. Anesthesia of rats was induced with inhalation of enflurane gas (alyraneTM, 
Pharmacia). Rats were kept asleep during the implantation procedure by a mix of 
enflurane (20%) and oxygen (80%). The back of each rat was shaved over a large area; 
the skin was disinfected with 0.5% chlorhexidine in 70% alcohol and allowed to dry. A 
10-mm incision was made at the base of the tail and the subcutis was dissected to create 3 
subcutaneous tunnels. In each rat, eight catheter fragments were inserted at least 2 cm 
from the incision; the distance between two fragments was at least 1 cm. 
For catheter explantation, rats were euthanized by CO2 inhalation. The skin was 
disinfected before removal of the catheter fragments. All catheter fragments from the 
same animal were used for a single time point. In each experiment, baseline gene 
expression levels in sessile bacteria before implantation were determined (time zero; n = 
16). A total of 176 polyurethane catheter segments were implanted and explanted at 11 
different time points. The time points used were 15 min (n = 16), 1 h (n = 16), 2 h (n = 
16), 4 h (n = 16), 6 h (n = 16), 12 h (n = 16), 24 h (n = 16), 2 days (n = 16), 4 days (n = 
16), 7 days (n = 16), and 14 days (n = 16). Data for each in vivo time point were obtained 
from 16 independent measurements generated in 2 independent experiments. DNA and 
RNA isolation and cDNA synthesis were performed immediately after explantation. 
 
3.2.5. DNA and RNA extraction and cDNA synthesis 
DNA and RNA were extracted from planktonic and sessile bacteria grown in vitro 
and in vivo as previously described (Vandecasteele et al. 2001;Vandecasteele et al. 2002). 
Briefly, for bacteria in suspension (planktonic bacteria), an aliquot of the bacterial 
suspension with a maximum of 109 CFU (colony forming unit) was rapidly cooled on ice. 
The bacteria were pelleted, and the pellet was suspended in 500 µl of NAES buffer (50 
mM sodium acetate [pH 5.1], 10 mM EDTA, 1% sodium dodecyl sulfate) and added to a 
FastRNA blue tube (Bio 101, Carlsbad, Calif.) with 500 µl acidified phenol-chloroform 
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(5:1; pH 4.5; Ambion, Austin, Tex.) at room temperature. For sessile bacteria, the 
colonized catheter fragment was washed with 1 ml of 0.9% NaCl and added directly to a 
FastRNA tube containing 500 µl of NAES buffer and 500 µl of acidified phenol-
chloroform. The FastRNA tubes were shaken for 23 s at 6000 rpm with a FastPrep 
instrument (FP 120; Bio 101, Savant, Holbrook, N.Y). After shaking, the tubes were 
centrifuged. 
After centrifugation, the supernatant was collected and precipitated with 520 µl of 
isopropyl alcohol and 35 µl of 3 M sodium acetate. The pellet was washed with 70% 
ethanol and resuspended in 150 µl of RNase-free water. Fifty microliters of this sample 
was diluted 1/10 and used for quantification of gDNA. The remaining 100 µl was purified 
with an RNeasy mini kit (Qiagen, Hilden, Germany) and treated with RNase-free DNase 
(Qiagen) on RNeasy columns according to the instructions of the manufacturer. The RNA 
was finally dissolved in 60 µl of RNase-free water. Reverse transcription of the RNA was 
performed with Moloney murine leukemia virus (MMLV) reverse transcriptase 
(Promega, Madison, Wisconsin, USA). 
For RT-PCR we used 100 U MMLV reverse transcriptase (Promega, Madison, 
Wisconsin, USA) with the supplied buffer, 20 U RNasin (Promega), 100 µM random 
hexamers (Amersham Pharmacia Biotech), 1 mM of each dNTP, 9 µl RNA for planktonic 
samples and 36 µl for samples of sessile bacteria in a total volume of 60 µl. Reaction 
conditions were as follows: preheating RNA sample for 10 min at 70°C followed by 
addition of the reaction mix. cDNA was prepared from this mixture through incubation 
for 1 h at 42°C followed by heating at 99°C for 2 min for enzyme denaturation and rapid 
cooling to 4°C. 
 
3.2.6. Taqman PCR 
Gene quantification was performed on the ABI Prism 7700 Sequence detection 
System (PE Applied biosystems) using primers and probes labeled with the reporter dye 
6-carboxy-fluorescein (6’-FAM) at the 5’ end and with the quencher dye 6-carboxy-
tetramethyl-rhodamine (TAMRA) at the 3’ end (Table 3.1.). In brief, quantitative PCR 
was done with 2 µl of cDNA, 12.5 µl of 2X Taqman PCR master mix (PE Applied 
Biosystems), 900 nM of each primer, and 200 nM probe in a final volume of 25 µl. 
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Table 3.1. List of primers and probes used in real time PCR gene quantification. 
 
 
ses 
gene 
 
Forward primer 5’… 3’ 
 
Reverse primer 5’… 3’ 
 
Probe, labeled FAM-5’ and 3’-TAMRA 
 
sesN 
 
AGCACGGAGAAGGTCAC
GAA 
 
GACTTACTACAGGATCCAAC
CAAATGT 
 
AACATCATCACCATGGAAAATACGACC
CA 
 
sdrG 
 
TCGATTAAACGTGTAACC
GTAAATCA 
 
TCACTATCATCATATCCTTCA
GTAATACTTTGA 
 
TAGCGGCGGAACAAGGTTCGAATGTT
AA 
 
sesO 
 
GGGTGGAGTCCTGATTAT
C 
 
TACTTGCGGATTCGTTAAG 
 
CCAGTCGCTCCTGTTTATC 
 
sesE 
 
TCAAGCCGGTGCTACGG
TTA 
 
ACCAGTTGCCGTTTGATCGT 
 
ATGGTCAAGACGGGAATCAA 
 
sesL 
 
TTGGGCAGATCATCTTGG
TTATAC 
 
GACTTACTACAGGATCCAAC
CAAATGT 
 
CTGATTTCGGTGAAACTGAATACGGAG
ATAATACAA 
 
sesJ 
 
CACTTGGGTAGATGGTTC
TAA 
 
TTTTTCCGGTGTATAATTGTT 
 
CTGCTTTGTTTTCTGGGAATGAA 
 
sesK 
 
CCCTAAAGATGAAACTAC
TGTTCATGAT 
 
TGCTATCCATTCGAAACTTTC
ATTAT 
 
ACAATGTGACAAAACAGGGTGTACTAA
AAGTAAACGAA 
 
sesP 
 
TCAACTGCAGCTGATTAT
GA 
 
GAGAGCACGTGGAGTATTTC 
 
TACGGACAGGCAGAAACGATAGG 
 
sesM 
 
AACCTTATCCAGAATTAA
TGTCTGAACTC 
 
CAGGTTGATCAGTTACTTTG
TTTTTAGC 
 
CAAGCCCATTTGCTGCTATTTACGACA
CAAA 
 
sesB 
 
GTGTATGCGGATGAAAAT
ACT 
 
CAGGGGTTTTAGCATCTTC 
 
CTGCAAACCAAAATCAAGGAACA 
 
sesQ 
 
GGGGATTATTTCACAATT
GA 
 
CACTGCTTGTGTCTGTTGAG 
 
AATAAATCTGGTGCAGGTGTCGG 
 
sesC 
 
AGCATCACCATCTAATAA
AAACGAAA 
 
CCATCATTACTTTTATCGTCT
TTACTATCAC 
 
TAACAAAGAAGAATCTAGTACGACAAC
AAATCAATCCGA 
 
sdrF 
 
ATTAGACCGGGTGGT 
 
CCGCTGCTGTAGTTGTATT 
 
TGGAAGTGACGATTGCTAACGA 
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Thermal cycling conditions were the following: 2 min at 50°C, followed by 10 min at 
95°C, followed by 45 repeats of 15 s at 95°C and 1 min at 60°C. Data collection was done 
during each annealing phase. During each run, a standard dilution of the plasmid with 
known quantity was included to permit gene quantification by means of the supplied 
software, according to the instructions of the manufacturer. In each run, a negative 
control (distilled water) was included. 
In this study, a relative quantification method was used. The number of copies of 
cDNA per ml (a measure of the amount of mRNA) was divided by the number of copies 
of gDNA per ml. This quotient represents the amount of gene expression per viable 
bacterium. 
 
3.2.7. Statistical analysis 
All statistical analyses of the in vitro and in vivo gene expression data were 
performed with GraphPad prism (GraphPad software version 4.2, San Diego, USA) as 
described (Massonet et al. 2006;Pintens et al. 2008;Vandecasteele et al. 
2003;Vandecasteele et al. 2004). Since the in vitro and in vivo cDNA/gDNA ratios were 
not normally distributed at any time point, all data were log10 transformed in order to 
fulfill the requirements of normality. 
For the in vitro gene expression data, two hypotheses were tested. A significant 
change in gene expression levels over time within one group (sessile or planktonic) was 
tested with a one-way analysis of variance (One-way ANOVA). A significant difference 
in the evolution over time of the gene expression levels between the sessile group and the 
planktonic group was tested with a two-way ANOVA. When the one-way ANOVA was 
significant, two-sided univariate tests with a correction for multiple comparisons were 
done (Bonferroni test) to locate the significant differences. 
For the in vivo gene expression data, a one-way ANOVA was used to test if there 
was a significant evolution of the expression levels over time. When the one-way 
ANOVA test was significant, the two-sided Bonferroni multiple-comparison method was 
used to determine which time points differed at α = 0.05, with a correction for multiple 
comparisons. 
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3.3. Results 
 
3.3.1. Expression of ses genes in planktonic and sessile bacteria in vitro and in vivo 
Expression of ses genes was compared between sessile bacteria and their 
planktonic counterparts during in vitro biofilm formation at different time points (Table 
3.2. and Figure 3.1.). Expression of ses genes in sessile bacteria at different time points 
during in vivo FBI in the rat model was compared to the baseline expression level at time 
point zero (Table 3.3. and Figure 3.2.). Different ses genes showed different patterns of 
gene expression, as are described below: 
 
sesN 
The in vitro expression of sesN significantly decreased in planktonic 
bacteria after inoculation but stayed relatively constant in sessile bacteria. On the 
other hand, expression of sesN in sessile bacteria was upregulated compared to 
their planktonic counterparts. 
 The in vivo expression of sesN increased and peaked at 4 h post-
implantation. Expression of sesN was high during early and late FBI. 
 
sdrG 
The in vitro and in vivo expression pattern of sdrG was similar to the 
expression pattern of sesN. 
 
sesO 
The in vitro expression of sesO increased in sessile bacteria 10 min after 
inoculation and then stayed constant. In planktonic bacteria sesO expression first 
decreased 10 min after inoculation and then increased to the same level of 
expression as found in sessile bacteria. 
 The in vivo expression of sesO was almost constant except for the late FBI 
during which it was upregulated. 
 
sesE 
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The in vitro expression of sesE sharply increased in sessile bacteria 
immediately after inoculation and stayed constant during the rest of the 
experiment. The expression of sesE increased in planktonic bacteria after 35 min. 
 The in vivo expression of sesE was almost constant except during the late 
FBI during which it was upregulated. 
 
sesL 
The in vitro expression of sesL in planktonic bacteria stayed constant 
throughout the experiment, but the sesL expression in sessile bacteria gradually 
increased and peaked 1 h after inoculation and stayed constant during the rest of 
the experiment. 
 The in vivo expression of sesL was upregulated during the early and late 
 FBI. 
 
sesJ 
The in vitro expression of sesJ in planktonic bacteria decreased 2 h post-
inoculation, whereas inoculation induced a sharp increase in sesJ expression in 
sessile bacteria which peaked at 35 min, thereafter sesJ expression decreased 
towards the expression level in their planktonic counterparts. 
 The in vivo expression of sesJ was upregulated during the early and late 
 FBI. 
 
sesK 
The in vitro expression of sesK in planktonic bacteria was constant 
throughout the experiment, whereas sesK expression in sessile bacteria increased 
1 h post-inoculation and stayed constant for the rest of the experiment. 
 The in vivo expression of sesK was upregulated during the early and late 
FBI similar to in vivo expression of sesJ. 
 
sesP 
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The in vitro expression of sesP in planktonic bacteria decreased 10 min 
post-inoculation, whereas in sessile bacteria it first increased between 10-35 min 
and then decreased towards the sesP expression level found in planktonic bacteria. 
 The in vivo expression of sesP was downregulated during the early FBI 
and was constant during the rest of the experiment time. 
 
sesM 
The in vitro expression of sesM in both planktonic and sessile bacteria 
decreased after inoculation and stayed constant. 
 The in vivo expression of sesM was upregulated during the early FBI and 
was constant during the rest of the experiment time. 
 
sesB 
The in vitro expression of sesB in planktonic bacteria was constant, 
whereas inoculation induced a sharp increase in sesB expression in sessile bacteria 
which stayed constant during the rest of the experiment. 
 The in vivo expression of sesB was downregulated during the early FBI 
and was constant during the rest of the experiment time. 
 
sesQ 
The in vitro expression of sesQ in planktonic bacteria decreased 1 h post-
inoculation, whereas sesQ expression in sessile bacteria sharply increased 
immediately after inoculation and stayed constant during the rest of the 
experiment. 
The in vivo expression of sesQ was downregulated during the early and 
late FBI. 
 
sesC 
The in vitro expression of sesC in both planktonic and sessile bacteria first 
decreased between 10 - 35 min and then increased towards the expression level at 
time point zero (T = 0). 
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 The in vivo expression of sesC was upregulated during the early and late 
FBI but downregulated at day 1. 
 
sdrF 
The in vitro expression of sdrF in planktonic bacteria was constant, 
whereas in sessile bacteria sdrF expression initially increased 10 min post-
inoculation and then returned to the expression level of time point zero (T = 0) 
between 35 min – 2 h and was again increased at time point T=3 h. 
 The in vivo expression of sdrF was unchanged during the early and late 
FBI except that it increased at the end of experiment (T = 2 weeks). 
 
 
3.4. Discussion 
 In this study, the evolution over time of the expression of S. epidermidis ses genes 
during in vitro and in vivo FBI was investigated. Timewise analysis of gene expression  
 
 
Table3.2. In vitro gene expression pattern of ses genes in sessile bacteria compared to their planktonic 
counterparts. ↑: Upregulation, ↔: No changes, ↓: Downregulation 
 
ses gene 0 min 10 min 35 min 60 min 120 min 180 min 
sesN ↔ ↑ ↑ ↑ ↑ ↑ 
sdrG ↔ ↑ ↑ ↑ ↑ ↑ 
sesO ↔ ↑ ↔ ↔ ↔ ↔ 
sesE ↔ ↑ ↔ ↔ ↔ ↑ 
sesL ↔ ↑ ↑ ↑ ↑ ↑ 
sesJ ↔ ↑ ↑ ↔ ↔ ↑ 
sesK ↔ ↑ ↑ ↑ ↑ ↑ 
sesP ↔ ↔ ↑ ↔ ↔ ↑ 
sesM ↔ ↔ ↔ ↔ ↔ ↔ 
sesB ↔ ↑ ↑ ↑ ↔ ↑ 
sesQ ↔ ↑ ↑ ↑ ↑ ↑ 
sesC ↔ ↔ ↔ ↔ ↔ ↔ 
sdrF ↔ ↔ ↔ ↔ ↔ ↑ 
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Figure.3.1. In vitro expression of ses genes in planktonic (□) and sessile (■) bacteria. Gene expression 
was quantified as the log10 cDNA/gDNA ratio on the Y axis. The error bars represent standard deviations. 
At each time point 8 samples from two independent experiments were assessed. The X axis indicates time 
(min). Whenever the gene expression in sessile bacteria compared to their planktonic counterparts was 
significantly different (p<0.05; 2-way-ANOVA) it was marked with a (*) for upregulation and a (§) for 
downregulation. 
 
 
Table3.3. In vivo gene expression pattern of ses genes in sessile bacteria over time compared to time point 
zero (T = 0). ↑: Upregulation, ↔: No changes, ↓: Downregulation 
 
ses gene 0 h 0.25 h 1 h 2 h 4 h 6 h 12 h 24 h 48 h 96 h 168 h 336 h 
sesN ↔ ↔ ↑ ↑ ↑ ↑ ↑ ↔ ↑ ↑ ↑ ↑ 
sdrG ↔ ↔ ↑ ↑ ↑ ↑ ↔ ↔ ↔ ↔ ↑ ↔ 
sesO ↔ ↔ ↔ ↔ ↔ ↔ ↓ ↔ ↔ ↑ ↑ ↔ 
sesE ↔ ↔ ↓ ↔ ↔ ↔ ↓ ↔ ↓ ↑ ↑ ↔ 
sesL ↔ ↔ ↑ ↑ ↑ ↑ ↔ ↔ ↑ ↑ ↑ ↔ 
sesJ ↔ ↑ ↑ ↑ ↑ ↔ ↔ ↑ ↑ ↑ ↑ ↔ 
sesK ↔ ↔ ↑ ↑ ↑ ↑ ↔ ↔ ↑ ↑ ↑ ↔ 
sesP ↔ ↓ ↔ ↔ ↔ ↔ ↓ ↔ ↔ ↔ ↔ ↔ 
sesM ↔ ↔ ↑ ↑ ↑ ↔ ↔ ↔ ↔ ↔ ↔ ↔ 
sesB ↔ ↔ ↓ ↓ ↔ ↔ ↓ ↔ ↔ ↔ ↔ ↔ 
sesQ ↔ ↓ ↓ ↔ ↔ ↔ ↓ ↔ ↔ ↓ ↔ ↔ 
sesC ↔ ↔ ↑ ↑ ↑ ↔ ↔ ↓ ↔ ↔ ↑ ↔ 
sdrF ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↔ ↑ 
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Figure.3.2. In vivo levels of expression of ses genes over time for two weeks after implantation. The 
expression level at any time point is represented as the log10 cDNA/gDNA ratio (Y axis) versus time (h) on 
the X axis. The error bars represent standard deviations. At each time point 16 samples from 2 independent 
experiments were assessed. Significant differences (p<0.05; 1-way-ANOVA) between any given time 
point, and time point zero (T=0) were marked by (*) for upregulation and (§) for downregulation. 
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during the course of biofilm development delivers significant information on the role of 
the genes studied (Massonet et al. 2006;Pintens et al. 2008;Vandecasteele et al. 
2003;Vandecasteele et al. 2004). However, gene expression studies cannot replace the 
information acquired with mutagenesis. 
The methodology used for gene expression studies has been shown to be 
sufficiently sensitive to document the time-dependent induction in vitro and in vivo of 
biofilm genes. Using this methodology, it has been shown that; i) the expression of ica 
operon genes was high during the colonization and establishment of biofilm formation 
(Vandecasteele et al. 2003), ii) aap expression was only upregulated during the 
accumulation phase (Pintens et al. 2008;Vandecasteele et al. 2003), iii) the expression 
levels of alkaline shock protein 23 (asp23) which is solely dependent on SigB, mirrored 
the expression pattern of sigB in both planktonic and sessile bacteria (Pintens et al. 2008), 
iv) the amount of 16S rRNA per genome as a determinant of metabolic activity was very 
low during late in vivo FBI which could explain at least in part resistance of biofilms to 
antimicrobial agents (Vandecasteele et al. 2004), v) the expression of sirR and the 
regulatory effect of sirR on the sitABC operon (iron-responsive genes) were different in 
planktonic and sessile bacteria (Massonet et al. 2006). 
Some general principles can be deduced from the gene expression patterns of 
genes with a proven role in biofilm formation such as ica operon genes, aap, and 16S 
rRNA. The sharp increase in expression of a gene after contact with the foreign body in 
vitro and in vivo might indicate a possible role of that gene in foreign body colonization. 
High levels of expression of a gene during the early and late in vivo FBI might be 
attributed to the importance of that gene in the establishment or maintenance of the 
biofilm, respectively. However, the increase in expression of a gene after the contact with 
the foreign body in vitro and in vivo might be either a direct consequence of the contact 
with the foreign body or mediated by regulatory systems. Expression of staphylococcal 
virulence factors and surface proteins is regulated by two previously identified regulatory 
loci, agr and sarA (Gill et al. 2005). The agr system in S. aureus and S. epidermidis 
downregulates the synthesis of surface proteins in response to changes in bacterial cell 
density at the onset of the stationary growth phase (Vuong et al. 2000). This might 
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partially explain why most of these genes were downregulated at time points 12 h and 24 
h. 
The sharp increase in sesO, E, J, B, Q expression in sessile bacteria in vitro after 
exposure to the foreign body, may lead to the assumption that these genes play a role in 
primary attachment. However, in vivo expression data do not confirm the in vitro data for 
these genes. This difference can be due to the different in vivo and in vitro environmental 
factors that can affect the expression of genes or the different factors which are important 
for attachment of bacteria to abiotic (in vitro condition) or biotic surface (in vivo) that is 
rapidly coated with extracellular matrix proteins (ECM) of the host. The in vitro increase 
in sesL, K, P expression in sessile bacteria occurred not immediately after the exposure to 
the foreign body and was not confirmed by in vivo gene expression results. 
Due to the lack of information about the role of these genes in biofilm formation, 
it is difficult to interpret in vitro gene expression patterns of ses genes. However, our data 
at least confirm previously reported results that showed upregulation and expression of 
sesN, sdrG, sesE, sesB, sesC, and sdrF genes in S. epidermidis biofilm-associated 
bacteria (Arrecubieta et al. 2007;Sellman et al. 2008;Yao et al. 2005a). 
The in vivo gene expression data suggest a role for sesN, G, L, J, K, M, C in the 
establishment of in vivo FBI, due to their upregulation in early FBI. Upregulation of sesN, 
O, E, L, J, K, C, F during the late in vivo FBI suggests a possible role for these genes in 
maintenance and persistence of in vivo FBI. sesN, L, J, K, C are genes which might play a 
role in the entire course of in vivo FBI, whereas the expression of sesP, B, Q was not 
upregulated during early or late in vivo FBI. 
 
 
3.5. Conclusion 
 Our data show that the selected genes are expressed in biofilm cells during in vitro 
and in vivo biofilm formation and confirm some previously reported gene expression 
data. However, additional functional study is necessary to explain the different in vitro 
and in vivo gene expression patterns. 
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4. Effect of rabbit polyclonal anti-Ses antibodies on S. 
epidermidis biofilm formation in vitro 
 
 
4.1. Introduction 
The in vitro and in vivo expression patterns of ses genes varied widely. Therefore 
and also due to the unknown role of the selected genes in biofilm formation, gene 
expression data alone were not sufficient for the selection of the best potential targets. 
Hence, we chose 5 out of 13 Ses proteins for further in vitro biofilm inhibition studies. 
The 5 proteins chosen include 3 LPXTG proteins with an uninvestigated role in biofilm 
formation and the 2 largest ABC transporters also with unknown function. We cloned, 
expressed and purified the extracellular part of these 5 selected Ses proteins. The 
recombinant Ses proteins (rSes) and ethanol killed bacteria [whole cell (WC)] were used 
to immunize rabbits. Total IgG from pre- and hyperimmune sera samples were purified 
and used in a semi-quantitative microtiter plate method (Christensen et al. 1985;Sun et al. 
2005) to evaluate the effect of IgG antibodies on S. epidermidis biofilm formation. 
 
 
4.2. Materials and methods  
 
4.2.1. Construction and purification of histidine-tagged fusion proteins 
Recombinant extracellular domains of the Ses proteins were expressed with 
hexahistidine tags at their N or C termini using the expression vector pET11c (Stratagene, 
LaJolla, CA). Each ses gene fragment was amplified using forward and reverse primers 
for each ses gene (Table 4.1.) which incorporate flanking NheI and BamHI restriction 
sites (in italics and underlined) and a sequence coding for a N or C-terminal His6 tag (in 
bold). Amplicons were cloned in pET11c and the resulting plasmids [pET11csesL, K, M, 
B, C] were transformed into E. coli BL21 (DE3). The resulting plasmids were used for 
recombinant protein production. 
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Recombinant truncated Ses proteins were expressed in E. coli BL21 (DE3) using 
the expression vector pET11c containing fragments of ses genes as previously described 
(Hermans et al. 2006). Briefly, after transformation, E. coli BL21 (DE3) was grown with 
shaking (250 rpm) at 37ºC in Luria-Bertani (LB) broth with 100 µg/ml ampicillin to an 
OD600nm (optical density at 600 nanometer) of 0.6-1.0. Expression was induced by 
addition of 1 mM IPTG for 2 h. After cooling on ice, cells were harvested by 
centrifugation (4000 rpm, 10 min at 4ºC) and resuspended in 5 ml imidazole buffer (20 
mM phosphate, 0.5 M NaCl, 10 mM imidazole) and frozen at -20ºC. Cells were first 
thawn on ice and then sonicated 3 times for 30 s. After centrifugation (30 min, 15000 rpm 
at 4ºC) the supernatant was used for Ni+ affinity chromatography purification of the 
recombinant proteins with the HisTrap™ Kit (Amersham Pharmacia, Uppsala, Sweden). 
The columns were washed with 40 mM imidazole buffer and proteins were eluted with 
300 mM imidazole buffer. The purified recombinant protein was dialyzed against 10 mM 
HEPES buffer, pH 7.5, freeze dried, and stored at -20 °C. From one liter of E. coli culture 
70 mg recombinant protein was purified. Purity of the recombinant proteins was 
determined by Coomassie blue staining of SDS-PAGE gel electrophoresis. The sequence 
of the purified peptide was confirmed by amino acid analysis and MALDI-TOF mass 
spectrometry. 
 
4.2.2. Preparation and purification of polyclonal anti-rSes proteins IgG antibodies 
Polyclonal antibodies were produced at Eurogentec (Seraing, Belgium) by 
immunization of rabbits with purified rSes proteins according to standard immunization 
protocols. Ethanol (80%) killed S. epidermidis ATCC 12228 were also used as whole cell 
preparation to raise serum against the complete surface of S. epidermidis. Briefly, specific 
pathogen free rabbits were immunized with 100 µg rSes proteins or killed bacteria in 
Complete Freund's Adjuvant (CFA) and boosters were given at 14, 28 and 56 days after 
the first immunization with 50 µg antigens in Incomplete Freund's Adjuvant (IFA) 
intraperitoneally. Pre-immune serum was taken before the first immunization. After 87 
days, the total blood of the rabbit was collected and the serum was stored at –20°C. 
Total IgGs from pre- and post-immune sera were purified by absorption to a 
protein-G column (GE-Healthcare) according to the manufacturer's instructions. Purity  
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Table 4.1. List of primers used for cloning in pET11c for production of recombinant Ses proteins. 
 
 
ses gene 
 
Forward primer 5’… 3’ 
 
Reverse primer 5’… 3’ 
 
sesL 
 
CACGTGCTAGCCATCACCATCACCATCACA
AAACGCAAGATGAAGCGAAA 
 
GGAACTCAAATTATTTATTAAGGATCCGCAT 
 
sesK 
 
CACGTGCTAGCGCTGAATCAAACACTTCAGT
TTCTTCT 
 
CTATTACCAAATACAGGTATGCATCACCATCACC
ATCACTAGGATCCGCAT 
 
sesM 
 
ACTGGCTAGCCATCACCATCACCATCACGG
GGGCACCTCAAGTACAG 
 
GTTACACCAGAATCTATCTATTAGGATCCGCAT 
 
sesB 
 
ACGTGCTAGCGCAGCCGAAGTAACATCTC 
 
CTCAATTCATACTACGTAGGTCATCACCATCACC
ATCACTAGGATCCGCAT 
 
sesC 
 
ACGTGCTAGCGCAGATTCAGAAAGTACATC 
 
GAACAGCTACAGCTGATCATCACCATCACCATC
ACTAGGATCCGCAT 
 
 
and reactivity of the purified IgGs against their respective rSes proteins was determined 
by Coomassie blue staining of SDS-PAGE gel electrophoresis and with ELISA and 
Western blot according to standard protocols. 
 
4.2.3. Recognition of Ses proteins by rabbit anti-Ses sera 
 To evaluate the presence of the respective proteins on the surface of S. 
epidermidis, an indirect ELISA and Western blot with the pre- and post-immune sera on 
purified recombinant protein and lysed S. epidermidis ATCC 12228 were performed 
according to standard protocols. The ELISA was considered positive when the OD of 
post-immune sera was at least twice as high as the OD of pre-immune sera. 
 
4.2.4. In vitro biofilm inhibition assays 
The effect of pre- and post-immune IgGs against rSes proteins on in vitro biofilm 
formation during the first 2 h, considered as primary attachment and overnight (14 h) was 
studied. For quantification of biofilms, 20 µl of frozen cultures of S. epidermidis strain 
10b were inoculated into 5 ml BHI and grown to the end-exponential growth phase in a 
CHAPTER 4: EFFECT OF ANTI-SES ANTIBODIES ON BIOFILM FORMATION IN VITRO 
 
 
 75
shaking incubator at 37°C. Cultures were subsequently diluted to an OD600 of 0.005 
(5×106 CFU/ml) in fresh BHI medium. 
To evaluate the effect of IgGs on primary attachment of S. epidermidis strain 10b, 
starting cultures were diluted to an OD600 of 0.005 and subsequently grown at 37°C to an 
OD600 of 1. Cultures then were mixed with either pre- or post immune IgGs (10 µg/ml) 
and after 2 h incubation at 4°C, 200 µl of the mixtures were pipetted into 96-well 
polystyrene microtiter plates (BD Biosciences, Heidelberg, Germany) and incubated for 2 
h at 37°C without shaking. 
To study the effect of IgGs on biofilm formation during 14 h, the cultures diluted 
to an OD600 of 0.005 were mixed with either pre- or post-immune IgGs (10 µg/ml) and 
after 2 h incubation at 4°C, 200 µl of the mixtures (106 cells per well) was added to each 
well of 96-well polystyrene microtiter plates, and incubated overnight at 37°C without 
shaking. 
After the incubation, plates were washed 3 times with phosphate buffered saline 
(PBS) (pH 6.8, containing 0.5 M NaCl and 10 mM EDTA) and adherent biofilms were 
stained with 200 µl of 1% (wt/vol) crystal violet (Sigma) for 10 min, after which the 
plates were washed 3 times with water and dried. For quantification, 160 µl of 30% 
(vol/vol) acetic acid was added to each well to dissolve the stain. The OD595 of the 
dissolved stain was measured in a multipurpose UV/VIS plate reader. Percent inhibition 
of biofilm formation was calculated by using the following formula: (A595, positive - A595, 
antibody)/(A595, positive - A595, negative) × 100% (Sun et al. 2005). Average inhibition at each 
concentration of IgGs was obtained from at least 8 independent measurements generated 
in at least 2 independent experiments. S. epidermidis strain 10b in BHI without any added 
IgGs was used as positive control, and BHI without bacteria was used as negative control. 
 
4.2.5. Statistical analysis 
For all data from bacterial adherence assays, two hypotheses were tested. A 
significant change in adherence levels by different IgGs within one group (pre-immune or 
anti-Ses IgGs) was tested with a one-way analysis of variance (1-way ANOVA). A 
significant difference in adherence with different IgGs between the pre-immune IgGs and 
anti-Ses IgGs groups was tested with a two-way ANOVA. When the one-way ANOVA 
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was significant, two-sided univariate tests with a correction for multiple comparisons 
were done (Bonferroni test) to locate the significant differences. 
 
 
4.3. Results 
 
4.3.1. Recognition of Ses proteins on the surface of S. epidermidis 
 Western blot analysis was positive on both recombinant protein and bacterial 
lysate for all anti-Ses sera except SesK where only the recombinant protein was 
recognized. Similarly, all recombinant proteins except for SesK were recognized by 
whole cell antisera. ELISA on their respective recombinant proteins and lyzed S. 
epidermidis ATCC 12228 was positive for all anti-Ses sera, whereas ELISA on whole 
cells was positive for anti-SesL, B, C sera and negative for anti-SesK, M sera. ELISA 
was negative for all pre-immune sera (Table 4.2.). 
 
 
Table 4.2. Western blot and ELISA results of immune sera against recombinant Ses proteins and whole cell 
S. epidermidis ATCC 12228. WC: whole cell 
 
Antiserum against 
on respective rSes protein on S. epidermidis lysate on WC S. epidermidis 
Western blot ELISA Western blot ELISA ELISA 
SesL + + + + + 
SesK + + - + - 
SesM + + + + - 
SesB + + + + + 
SesC + + + + + 
WC +*** + + + + 
 
***: Western blot with whole cell antiserum on recombinant proteins was positive for all proteins except 
SesK 
 
 
4.3.2. Biofilm inhibition by purified polyclonal anti-rSes IgGs 
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The maximum inhibition of initial attachment of the bacteria to the polystyrene 
surface compared to the controls (bacteria pre-incubated with pre-immune IgGs or 
without IgGs) was caused by the total IgGs purified from serum of the rabbit immunized 
with rSesC [95% confidence interval (CI) of diff. 7.646 to 44.49; p<0.01; as determined 
by a Bonferroni test] (Figure 4.1.). 
 
 
  
 
Figure 4.1. Effect of total IgGs purified from pre-immune (□) and anti-Ses (L, K, M, B, C) and anti-
WC sera (■) on primary attachment of S. epidermidis 10b to polystyrene surface. Bacteria were mixed 
with IgGs and incubated for 2 h at 4°C and then pipetted into the wells. After 2 h incubation at 37°C, plates 
were washed and stained with crystal violet and the OD595 was measured. The error bars indicate standard 
deviations. Data are the average of 8 measurements in 2 independent experiments. Biofilm inhibition was 
defined in the text. WC: whole cell 
 
 
A 2 h pre-incubation of bacteria with different IgGs followed by an overnight (14 
h) incubation in the 96-well polystyrene microtiter plates showed that the maximum 
inhibition of biofilm formation was caused again by total IgGs purified from rSesC 
induced rabbit antisera (Figure 4.2.). However, this reduction was not statistically 
significant. 
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Figure 4.2. Inhibition of S. epidermidis 10b biofilm formation by total IgGs purified from pre-
immune (□) and anti-Ses (L, K, M, B, C) and anti-WC sera (■). Overnight culture were diluted to an 
OD600 of 0.005, mixed with the IgGs and incubated for 2 h at 4°C and then pipetted into the wells and 
incubated overnight (14 h) at 37°C. Formation of biofilm was measured with crystal violet stain and biofilm 
inhibition was calculated as was explained in the text. The error bars indicate standard deviations. Data are 
the average of at least 8 independent measurements in 2 independent experiments. WC: whole cell 
 
 
4.4. Discussion 
 
Using ELISA and Western blotting techniques, it has been shown that the selected 
proteins are surface-exposed except for SesK and SesM which might be surface-exposed 
proteins that are expressed under specific, unknown circumstances. 
 The in vitro expression of sesL, K, B genes was upregulated in sessile bacteria 
compared to their planktonic counterparts. However, the sharp increase after exposure to 
the foreign body was only induced in sesB. The in vitro expression of sesM, C decreased 
after the exposure to foreign body and was similar in sessile and planktonic bacteria. 
During the first 4 h after the implantation of catheter fragments in rats the in vivo 
expression of sesL, K, M, C genes increased whereas sesB expression decreased (Chapter 
3.3.). 
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Based on the gene expression data we expected that anti-SesB IgGs would show 
the highest effect on primary attachment. However, as it has been previously explained 
(Chapter 3.4.), interpretation of gene expression patterns without knowing the function of 
the protein encoded by that gene is not easy. Whether the proteins predicted to be surface-
exposed are true surface-exposed proteins or if after translation and translocation the level 
of proteins on the surface is correlated with the gene expression levels are important 
questions that make the interpretation of gene expression results difficult. 
Most likely, whole killed bacteria are not suitable antigens for antibody-mediated 
inhibition of biofilms. Although antibodies to the whole surface fraction of planktonic 
bacteria may opsonize the bacteria for phagocytosis, it is possible that such polyclonal 
antibodies inhibit the function of surface proteins such as AgrC which in turn repress the 
agr activity which in turn increases expression of colonizing factors and induce biofilm 
formation. 
There are several explanations for the low effect of anti-Ses IgGs on S. 
epidermidis biofilm formation: i) expression of proteins on the surface is low, ii) 
polyclonal antibodies cross react with other non-specific antigens, iii) the concentration 
of antibodies which was used was not sufficient for inhibition of the function of some Ses 
proteins. However, since our aim was to identify the best potential target for further 
investigation, we didn’t test different concentrations of different anti-Ses IgGs. 
 
 
4.5. Conclusion 
Based on the effect of different IgGs on primary attachment and inhibition of 
biofilm formation, SesC was selected for further investigation. 
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5. Expression of SesC protein on the surface of planktonic and 
sessile bacteria 
 
This chapter is based on the following reference: Mohammad Shahrooei, Vishal Hira, Rita Merckx, Benoit 
Stijlmans, Peter W.M. Hermans, Johan Van Eldere. 2009. Inhibition of Staphylococcus epidermidis biofilm formation 
by rabbit polyclonal antibodies against SesC protein. Infection and Immunity. 77(9):3670-8. 
 
 
5.1. Introduction 
SesC was selected as the best target antigen based on the effect of total IgGs 
purified from serum of rabbit immunized with rSesC on S. epidermidis biofilm formation 
in vitro. In order to validate the in vitro sesC expression pattern (Chapter 3), conventional 
fluorescence microscopy was used to confirm SesC protein expression on the surface of 
sessile and planktonic S. epidermidis bacteria in vitro. 
 
 
5.2. Materials and methods 
 
5.2.1. Purification of polyclonal specific anti-SesC IgG antibodies 
In order to enrich for polyclonal specific anti-SesC IgGs (αSesC-IgGs), the rSecC 
antigen was covalently coupled to the MiniLeak (Medium) affinity resin (Kem-En-Tec, 
Copenhagen, Denmark) as recommended by the manufacturer. In total, 1 mg rSecC was 
coupled to 1 ml resin and the coupling efficiency was measured as described by the 
manufacturers. Subsequently, 5 ml of purified IgG was incubated for 3 h at room 
temperature with 1 ml of immunoaffinity resin and was subsequently packed into a 
column. After washing the resin with 100 ml of PBS, immunoabsorbed material was 
eluted with 0.1 M glycine-HCl buffer, pH 2.7 and immediately dialysed against PBS. 
After dialysis, the concentration was determined spectrophotometrically at OD280 (1.4 
OD=1 mg/ml). Purity of the IgGs was determined by Coomassie blue staining of SDS-
PAGE gel electrophoresis. 
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The affinity of IgGs purified from pre-immune serum, and polyclonal αSesC-IgGs 
isolated from antiserum against rSesC was quantified with an alkaline phosphatase 
conjugated anti-rabbit immunoglobulin by indirect protein ELISA according to standard 
protocols. 
 
5.2.2. In vitro protein expression studies 
In order to validate the in vitro sesC expression pattern (Chapter 3), conventional 
fluorescence microscopy was used to confirm SesC protein expression on the surface of 
sessile and planktonic S. epidermidis bacteria in vitro. Preparation of samples for 
fluorescence microscopy was similar to preparation of samples for gene expression 
analysis in vitro with the exception that samples were taken at different time points (0, 
30, 60, 90 and 120 min) after inoculation and sessile cells were separated from catheter 
fragments by sonication for 10 min at 40 kHz in a water bath (Branson 2200, Branson 
Ultrasonics). The bacteria were fixed using PBS containing 1.5% formaldehyde and 0.5% 
glutaraldehyde for 30 min, and washed with PBS. Next, the bacteria were pre-incubated 
for 20 min on ice with 2.4G2 (Fc-blocking antibody, BD Pharmingen), after which 
αSesC-IgGs were added at 5 µg per 100 µl for another 30 min. Subsequently, the bacteria 
were washed twice with ice-cold PBS and FITC-labeled goat-anti-rabbit antibodies (BD-
Pharmingen) was added for 30 min. Finally, the cells were washed twice with PBS and 
viewed with a fluorescence microscope (Leica, Germany) equipped with an oil-
immersion plan neofluar objective (100X; numeric aperture=1.25). 
The following samples were used as negative controls: 1) cells incubated with 
pre-immune IgGs and FITC-labeled goat-anti-rabbit antibodies, 2) cells incubated with 
polyclonal rabbit antibody against mouse immunoglobulins and FITC-labeled goat-anti-
rabbit antibodies, 3) cells incubated with only FITC-labeled goat-anti-rabbit antibodies. 
 
 
5.3. Results 
 
5.3.1. Affinity of αSesC-IgGs to SesC protein 
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 Binding of the purified pre-immune IgGs and of the αSesC-IgGs was tested via an 
indirect ELISA against the 65 kDa rSesC. Increasing concentrations of purified pre-
immune IgGs and αSesC-IgGs showed no binding of pre-immune IgGs and a dose-
dependent binding of the purified anti-SesC IgGs (Figure 5.1.). 
 
 
  
 
Figure 5.1. Affinity of pre-immune (□) and αSesC-IgGs (■) to rSesC. An indirect ELISA was performed 
using a 96-well ELISA plate coated with rSesC. IgGs were added to each well and incubated for 3 h at 
37°C. Bound IgGs were measured at OD405 with an alkaline phosphatase conjugated anti-rabbit 
immunoglobulin. X and Y axes indicate log10 [IgG concentration (ng/ml)] and OD405 absorbance, 
respectively. 
 
 
5.3.2. SesC protein expression in sessile and planktonic bacteria in vitro 
To confirm the results obtained from gene expression analysis, purified polyclonal 
αSesC-IgGs and FITC-labelled goat-anti-rabbit antibodies were used in an 
immunofluorescence assay to study in vitro protein expression. Comparison of the images 
taken by fluorescence microscopy from sessile and planktonic bacteria at different time 
points confirmed the protein expression of SesC on the surface of both sessile and 
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planktonic S. epidermidis 10b bacteria. Visual comparison of images taken at different 
time points suggested a higher level of fluorescence, in sessile compared to planktonic 
bacteria (Figure 5.2.). No quantitative measurements were however performed. These 
data show that gene expression patterns of sesC correlate with SesC protein expression. 
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Figure 5.2. In vitro sesC gene expression and extracellular presence of the SesC protein in planktonic 
and sessile bacteria. Gene expression is quantified as the log10 cDNA/gDNA ratio on the Y axis. The error 
bars represent standard deviations. At each time point 8 samples from 2 independent experiments were 
assessed. The X axis indicates time (min). 
Fluorescence microscopy images are from sessile bacteria (top) and planktonic bacteria (bottom) 
at different time points. Images A1 and A2 show bacterial cells plus pre-immune IgGs and FITC-labelled 
goat-anti-rabbit antibodies. Images B1 and B2 are from control samples containing bacterial cells plus 
polyclonal rabbit antibody against mouse immunoglobulins and FITC-labelled goat-anti-rabbit antibodies. 
Images C1 and C2 are from control samples of bacterial cells plus only FITC-labelled goat-anti-rabbit 
antibodies. A1, B1 and C1 were visualized by fluorescence while A2, B2 and C2 were visualized by bright-
field microscopy. 
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5.4. Discussion 
Protein expression studies showed that SesC is an extracellular protein that is 
expressed on the surface of both planktonic and sessile bacteria. Comparison of the 
images taken by fluorescence microscopy from sessile and planktonic bacteria suggested 
a higher level of fluorescence staining (meaning protein expression) in sessile bacteria 
compared to their planktonic counterparts. There was also a higher gene expression level 
in sessile compared to planktonic bacteria, however this was not statistically significant. 
Quantification of the difference in protein expression between sessile and planktonic 
bacteria was not performed because it was not important for our study. 
 
 
5.5. Conclusion 
In conclusion, SesC is a surface-exposed protein of which the expression is 
slightly higher in sessile cells compared to their planktonic counterparts. 
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6. Effect of specific anti-SesC antibodies on S. epidermidis 
biofilm formation in vitro 
 
This chapter is based on the following reference: Mohammad Shahrooei, Vishal Hira, Rita Merckx, Benoit 
Stijlmans, Peter W.M. Hermans, Johan Van Eldere. 2009. Inhibition of Staphylococcus epidermidis biofilm formation 
by rabbit polyclonal antibodies against SesC protein. Infection and Immunity. 77(9):3670-8. 
 
 
6.1. Introduction 
Based on the effect of rabbit polyclonal antibodies on in vitro S. epidermidis 
biofilm formation, the surface-exposed protein SesC was selected as the best potential 
antigen for further investigation. Prior to an evaluation of whether SesC is a promising 
target for immunoprophylaxis and immunotherapy against S. epidermidis biofilms, the 
effect of αSesC-IgGs was tested in vitro on S. epidermidis biofilms at different stages. 
Compared to the in vivo experiments, the in vitro experiments are inexpensive, 
rapid and easy to perform assays in which the experimental conditions can be easily 
controlled. 
 
 
6.2. Materials and methods 
 
6.2.1. Effect of αSesC-IgGs on in vitro primary attachment 
The effect of pre-immune or αSesC-IgGs on in vitro primary attachment was 
studied using a semi-quantitative adherence assay on 96-well polystyrene microtiter 
plates as previously described (Chapter 4.2.4.). Briefly, 20 µl of frozen cultures of S. 
epidermidis strains 10b and 1457 were inoculated into 5 ml BHI and grown to the end-
exponential growth phase in a shaking incubator at 37°C. Cultures were subsequently 
diluted to an OD600 of 0.005 (5×106 CFU/ml) in fresh BHI medium and grown to an 
OD600 of 1. Cultures then were mixed with either pre-immune IgGs or αSesC-IgGs (10 
µg/ml) and after 2 h incubation at 4°C, 200 µl of the mixtures were pipetted into 96-well 
polystyrene microtiter plates and incubated for 2 h at 37°C without shaking. After 2 h 
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incubation, adherent bacteria were quantified and percent inhibition was calculated as 
previously described (Chapter 4.2.4.). 
 
6.2.2. Effect of different concentrations of αSesC-IgGs on in vitro biofilm formation 
during 14 h 
To study the effect of pre-immune or αSesC-IgGs on biofilm formation during 14 
h, the overnight cultures of S. epidermidis strains 10b, 1457 and a biofilm-forming sesC-
negative clinical isolate of S. warneri (This study) were diluted to an OD600 of 0.005, 
mixed with either pre-immune IgGs or αSesC-IgGs in concentrations of 1-4 µg/ml. The 
mixtures were incubated for 2 h at 4°C. 200 µl of the mixtures (106 cells per well) was 
added to each well of 96-well polystyrene microtiter plates, and incubated overnight at 
37°C without shaking. After 14 h incubation, biofilms were quantified and biofilm 
inhibition was calculated as described previously (Chapter 4.2.4.). 
 
6.2.3. Effect of αSesC-IgGs on 1-day old biofilms in vitro 
To evaluate the effect of αSesC-IgGs on 1-day old biofilms of 10b, the diluted 
overnight cultures of bacteria with an OD600 of 0.005 were pipetted into sterile 96-well 
polystyrene microtiter plates and incubated overnight at 37°C without shaking. After 24 h 
incubation, growth medium was replaced with fresh medium or fresh medium containing 
2.5, 5 or 10 µg/ml pre-immune IgGs or αSesC-IgGs and incubated overnight at 37°C 
without shaking. After 14 h incubation, the remaining biofilms were quantified and 
percent detachment was calculated using the same formula used for calculating percent 
inhibition (Chapter 4.2.4.). 
 
6.2.4. Effect of αSesC-IgGs on biofilm formation of bacteria isolated from 1-day old 
biofilms 
To examine whether the αSesC-IgGs has the same effect on biofilm formation of 
10b bacteria isolated from an established biofilm (Sessile origin) as on biofilm formation 
of planktonic bacteria from an overnight culture, bacteria were isolated from 1-day old 
biofilms on catheter fragments by sonication for 10 min at 40 kHz in a water bath 
(Branson 2200, Branson Ultrasonics). The overnight cultures of planktonic bacteria and 
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suspensions of bacteria isolated from biofilm were adjusted to an OD600 of 0.005 and 
were mixed with αSesC-IgGs (2.5 and 5µg/ml) and after 2 h incubation at 4°C, 200 µl of 
the mixtures were added to each well (106 cells per well) of 96-well polystyrene 
microtiter plates, and incubated overnight (14 h) at 37°C without shaking. Biofilms were 
quantified and biofilm inhibition was calculated as described previously (Chapter 4.2.4.). 
 
6.2.5. Statistical analysis 
 Statistical analyses were performed with GraphPad prism 4.2. as previously 
described (Chapter 4.2.5.) with the exception that a significant change in adherence levels 
by different concentrations of IgGs within one group (pre-immune or αSesC-IgGs) was 
tested with a one-way analysis of variance (1-way ANOVA) instead of a significant 
change in adherence levels by different IgGs within one group (pre-immune or anti-Ses 
IgGs). 
 
 
6.3. Results 
 
6.3.1. Effect of αSesC-IgGs on primary attachment 
Pre-incubation of strains 10b and 1457 for 2 h with αSesC-IgGs or pre-immune 
IgGs at 4°C and subsequent incubation for 2 h in the polystyrene wells lead to a 
significant reduction of initial attachment compared to controls for αSesC-IgGs (p<0,01; 
1-way-ANOVA), but not for pre-immune IgGs (Figure 6.1.). 
 
6.3.2. Effect of different concentrations of αSesC-IgGs on biofilm formation during 
14 h 
A 2 h pre-incubation of bacteria with IgGs followed by an overnight (14 h) 
incubation in the 96-well polystyrene microtiter plates showed that the polyclonal αSesC-
IgGs purified from rSesC induced rabbit antisera exhibited a dose-dependent S. 
epidermidis biofilm inhibition activity, whereas the purified IgGs from pre-immune 
serum showed only low activity that was dose-independent (Figure 6.2.). Increasing the 
concentration of polyclonal αSesC-IgGs from 1 to 4 µg/ml increased S. epidermidis 
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strains 10b and 1457 biofilm inhibition from 40 to 80% (Figure 6.2.A. & B.). For both 
strains, the inhibition effects seen with αSesC-IgGs, were significantly different from that 
obtained with pre-immune IgGs (p<0.01; 2-way-ANOVA). 
A sesC-negative biofilm-positive S. warneri strain was included as control; for 
this strain the inhibitory effect of αSesC-IgGs was not significantly different from that of 
the pre-immune serum and was not dose-dependent (Figure 6.2.C.). For all 3 strains, the 
effect of pre-immune IgGs on the biofilm formation was non-significant and dose-
independent (p>0.05; 1-way-ANOVA). 
 
 
  
 
Figure 6.1. Effect of pre-immune (□) and αSesC-IgGs (■) on primary attachment of S. epidermidis 
10b and 1457 to polystyrene surface. Bacteria were mixed with IgGs and incubated for 2 h at 4°C and 
then pipetted into the wells. After 2 h incubation at 37°C, plates were washed and stained with crystal violet 
and the OD595 was measured. The error bars indicate standard deviations. Data are the average of 8 
measurements in 2 independent experiments. 
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Figure 6.2. Inhibition of biofilm formation by S. epidermidis strains 10b (A), 1457 (B) and a sesC-
negative biofilm-positive clinical isolate of S. warneri (C) with increasing concentrations of pre-
immune (□) and αSesC-IgGs (■). Overnight cultures were diluted to an OD600 of 0.005, mixed with the 
indicated concentration of IgGs and incubated for 2 h at 4°C and then pipetted into the wells. After 14 h 
incubation at 37°C, biofilms were quantified at OD595. The error bars indicate standard deviations. At each 
concentration of IgGs at least 9 independent measurements from 3 independent experiments were assessed. 
X and Y axes represent concentrations of IgGs (µg/ml) and % biofilm inhibition, respectively. 
 
 
6.3.3. Effect of αSesC-IgGs on 1-day old biofilms in vitro 
Addition of αSesC-IgGs on 1-day old biofilms of strain 10b induced a statistically 
significant dose-dependent decrease in established biofilms compared to biofilms treated 
with pre-immune IgGs (p<0,001; 2-way ANOVA) (Figure 6.3.). 
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6.3.4. Effect of αSesC-IgGs on biofilm formation by planktonic and isolated bacteria 
from biofilm  
Effect of different concentrations of αSesC-IgGs on biofilm formation of both 
planktonic and sessile bacteria (isolated from 1-day old biofilms on catheter fragments) 
was significant, dose-dependent and similar (Figure 6.4.). 
 
 
   
 
Figure 6.3. Effect of increasing concentrations of pre-immune (□) and αSesC-IgGs (■) on 1-day old 
biofilms of S. epidermidis 10b on polystyrene surface in vitro. Growth media after 24 h incubation at 
37°C were replaced with fresh BHI (control) or BHI containing 2.5, 5, and 10 µg/ml pre-immune or αSesC-
IgGs and then incubated for 14 h at 37°C. Remaining biofilms were stained with crystal violet and 
quantified at OD595 as shown on the Y axis. The X axis represents the IgG concentration (µg/ml). The error 
bars indicate standard deviations. Data are the average of 8 measurements in 2 independent experiments. 
 
 
6.4. Discussion 
 In vitro experiments showed that rabbit polyclonal αSesC-IgGs could significantly 
reduce primary attachment of S. epidermidis to the abiotic surface of polystyrene plates 
and inhibit biofilm formation by S. epidermidis strains 10b and 1457 up to 80% in a dose-
dependent manner. In contrast, the effect of rabbit polyclonal αSesC-IgGs on biofilm 
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Figure 6.4. Effect of αSesC-IgGs on biofilm formation of S. epidermidis 10b bacteria from an 
overnight culture origin or isolated from an established (1-day) biofilm on catheter fragments. 
Formation of biofilm was measured with crystal violet stain. The error bars indicate standard deviations. 
Data are the average of 8 measurements in 2 independent experiments. 
 
 
formation of a sesC-negative biofilm-positive S. warneri was non-significant, dose-
independent and limited. αSesC-IgGs also showed activity against the most difficult-to-
treat 1-day old biofilms in vitro. αSesC-IgGs could significantly reduce 1-day old 
biofilms of 10b on polystyrene microtiter plates in vitro in a dose-dependent manner. 
Pintens et al. (personal communication-unpublished data) showed that agr 
mutations occur naturally in mature S. epidermidis biofilms at a relatively high rate, thus 
increasing the colonization and biofilm forming ability of these mutants. To investigate 
whether such spontaneous mutations occur in sesC in biofilms or whether biofilm 
formation by such agr mutants can be affected by αSesC-IgGs, the effect of αSesC-IgGs 
on biofilm formation of cells isolated from established biofilms was investigated. Data 
showed that αSesC-IgGs had the same effect on biofilm formation of cells isolated from 
an established biofilm as on biofilms formed by cells from an overnight culture. 
Antibodies with complement proteins mediate opsonophagocytic killing of 
bacteria (Cerca et al. 2006). Another possible mechanism of action of antibodies is the 
inhibition of the function of a protein or ligand-receptor interactions which are caused by 
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conformational changes upon antigen binding (Brown and Koshland 1977;Einhauer and 
Jungbauer 2003;Oda et al. 2003). A possible mechanism for the effect of αSesC-IgGs on 
S. epidermidis biofilms in the absence of immune system components is probably that 
binding of αSesC-IgGs to SesC inhibits the function of SesC and thus biofilm formation. 
These data are suggestive for; i) a possible role for SesC in S. epidermidis 
attachment to the polystyrene surface and biofilm formation, ii) potential use of SesC as a 
target antigen for inhibition of biofilm formation and treatment of established biofilms. 
 
 
6.5. Conclusion 
 SesC might play a role in primary attachment of S. epidermidis to polystyrene 
surfaces and biofilm formation. SesC is a promising target for inhibition and treatment of 
S. epidermidis biofilms. 
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7. Effect of specific anti-SesC antibodies and immunization 
with SesC on S. epidermidis biofilm formation in vivo 
 
This chapter is based on the following reference: Mohammad Shahrooei, Vishal Hira, Rita Merckx, Benoit 
Stijlmans, Peter W.M. Hermans, Johan Van Eldere. 2009. Inhibition of Staphylococcus epidermidis biofilm formation 
by rabbit polyclonal antibodies against SesC protein. Infection and Immunity. 77(9):3670-8. 
 
 
7.1. Introduction 
So far, it has been shown that antibodies against the surface-exposed protein SesC 
can prevent the primary attachment, inhibit the accumulation phase and detach bacteria 
from an established S. epidermidis biofilm. These data demonstrating inhibition of 
biofilm formation with αSesC-IgGs in vitro indicate the relevance of SesC in S. 
epidermidis biofilm formation and the potential use of SesC as a promising target for 
vaccine development against S. epidermidis biofilms. However, expression and factors 
involved in biofilm formation in vitro and in vivo are different. For example in in vivo 
conditions, the surface of implants is rapidly coated by ECM proteins which are absent in 
in vitro conditions and are bound by different MSCRAMMs. These MSCRAMMs can 
promote adherence of bacteria to biotic surfaces. 
 In this chapter, using the rat model for FBI, the effect of anti-SesC antibodies 
(passive immunization) and immunization with SesC (active immunization) on S. 
epidermidis biofilm formation are investigated. 
 
 
7.2. Materials and methods  
 
7.2.1. Effect of αSesC-IgGs on 1-day old biofilms in vivo 
For the in vivo inhibition assay, the rat model for in vivo catheter infection was 
used. Seven mm catheter fragments, pre-incubated for 20 min at 37°C with S. epidermidis 
10b (≈104 cells/catheter) before implantation, were placed on ice and 8 fragments per rat 
were implanted immediately in EGF rats. After 24 h, the rats (9 rats divided into 3 groups 
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of 3 rats) were treated with 50 µg αSesC-IgGs diluted in PBS (total volume 330 µl), 50 
µg pre-immune IgGs diluted in PBS (total volume 330 µl) or 330 µl of PBS via a 
subcutaneous injection at the place of catheter insertion. 
Twenty-four hours after the injections, all 8 catheters from each rat were 
explanted and used for nucleic acid extraction as described (Vandecasteele et al. 
2001;Vandecasteele et al. 2002). Real-time quantitative PCR of the guanylate 
monokinase housekeeping gene [gmk (SE0885: NP_764440)] was used to quantify the 
number of bacteria attached to the catheter fragments. Primers and probe for gmk were 
previously described (Pintens et al. 2008). As previously demonstrated (Vandecasteele et 
al. 2002), the number of gmk copies per catheter correlates very well with the number of 
CFU per catheter. 
 
7.2.2. Effect of immunization of rats with rSesC on biofilm formation 
For vaccination experiments, nine EGF rats were divided into 3 groups of 3 rats. 
Each rat in the first group was immunized twice (interval of 2 weeks) with respectively 
100 and 50 µg rSesC (dissolved in normal saline) in CFA and IFA intraperitoneally. The 
second group of rats was injected with the same volume of normal saline in CFA and IFA 
but without antigen (rSesC). The third group was not immunized at all. The immune 
response after the second immunization of groups 1 and 2 were tested by ELISA of pre 
and post immunization sera samples of all rats. Subsequently, six catheter fragments pre-
incubated with S. epidermidis 10b bacteria (≈104 cells/catheter) were implanted in each 
rat and 24 h later explanted and the numbers of sessile cells were quantified by CFU 
counting as previously described (Pintens et al. 2008). Briefly, after gentle cleaning with 
0.9 % NaCl, catheters were placed in a tube containing 1 ml 0.9 % NaCl. Tubes were 
vortexed for 10 s, sonicated for 10 min at 40 kHz in a water bath (Branson 2200, Branson 
Ultrasonics) and again vortexed for 10 s. Thereafter, tube contents were diluted and 50 µ l 
aliquots of 10-fold dilutions were plated on Tryptone Soya Agar (TSA, Oxoid) plates 
using a spiral plating system. Colonies on all plates were counted and the number of 
bacteria was defined as the mean of at least six quantitative cultures. 
 
7.2.3. Statistical analysis 
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Statistical analyses were performed with GraphPad prism 4.2. A significant 
difference in adherence of bacteria to the catheter fragments between the controls and 
vaccine or treated groups with antibodies was tested with a one-way ANOVA. 
 
 
7.3. Results 
 
7.3.1. Effect of αSesC-IgGs on 1-day old biofilms in vivo 
In the in vivo rat model, the number of sessile bacteria was quantified after one 
day by quantification of gDNA copies of the housekeeping gene gmk. Injection of 50 µg 
pre-immune IgGs reduced the number of biofilm-associated S. epidermidis 10b bacteria 
0.64 log10 or 4-fold (p<0,01; 1-way ANOVA) whereas injection of 50 µg αSesC-IgGs 
decreased the number of biofilm-associated bacteria 1,78 log10 or 60.42-fold and 1.15 
log10 or 14.35-fold (p<0,001; 1-way ANOVA) compared to the control group injected 
with PBS and the group injected with pre-immune IgG, respectively (Figure 7.1.). 
 
7.3.2. Effect of immunization with rSesC on biofilm formation 
The number of sessile bacteria attached to the catheter fragments 24 h after 
implantation in the immunized group with rSesC compared to normal saline-immunized 
and non-immunized control groups, was 1.1 log10 or 12.5-fold reduced (p<0.01; 1-way 
ANOVA). Data for each group were obtained from adherent bacteria to 18 catheter 
fragments implanted in 3 rats (Figure 7.2.). 
 
 
7.4. Discussion 
 Data on the effect of passive and active immunization in our in vivo rat model for 
FBI are in line with our previous data on the effect of αSesC-IgGs on S. epidermidis 
biofilms in vitro. They indicate the relevance of SesC in S. epidermidis biofilm formation 
and the potential use of SesC as a target for vaccine development against S. epidermidis 
biofilms. 
CHAPTER 7: EFFECT OF IMMUNIZATION WITH SESC ON BIOFILM FORMATION IN VIVO 
 
 
 101
  
 
Figure 7.1. Effect of αSesC-IgGs on 1-day old biofilm of S. epidermidis 10b in vivo. One-day old 
biofilms on catheter fragments, implanted in 3 groups of rats (n=3 in each group), were subsequently 
treated with 50 µg pre-immune IgGs or αSesC-IgGs diluted in PBS (total volume 330 µl) or PBS via a 
subcutaneous injection at the place of catheter insertion. The next day, catheter fragments were explanted 
and the number of sessile bacteria was quantified by quantification of gDNA copies of the housekeeping 
gene gmk, represented on the Y axis. On the X axis the groups are indicated. The error bars represent 
standard deviations. Data for each group were obtained from adherent bacteria to 24 catheter fragments 
implanted in 3 rats. 
 
 
The effect of αSesC-IgGs on S. epidermidis biofilms in vitro, in the absence of  
immune system components suggested a neutralizing effect for antibodies which block 
the function of SesC. Our preliminary data from an in vitro opsonophagocytosis assay 
suggest an opsonic activity of αSesC-IgGs (data not shown). However, these data were 
not statistically significant and the exact mechanism of action of antibodies on S. 
epidermidis biofilms in vitro and in vivo and the precise role of SesC in biofilm formation 
remains to be identified. 
 A technical limitation of our in vivo model is the quantification of the 
subcutaneous concentration of antibodies. The subcutaneous injection of 50 µg of αSesC-  
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Figure 7.2. Effect of vaccination of EGF rats with rSesC on S. epidermidis 10b biofilm formation. The 
columns show the average load of bacteria on 18 catheter fragments 24 h after implantation. The error bars 
indicate standard deviations. Experiments were repeated twice. 
 
 
IgGs at the place of insertion of the catheter fragments reduced the number of attached 
bacteria to the catheter fragments 1.78 log10 or 60.42-fold compared to the control group. 
In the vaccinated group compared to the controls the number of attached bacteria was 
reduced 1.1 log10 or 12.5-fold. A possible explanation for such difference (1.78 log10 or 
60.42-fold vs. 1.1 log10 or 12.5-fold) between the effect of antibody injection and 
vaccination might be the higher concentration of antibodies at the place of infection in the 
passive immunization model. 
 
 
7.5. Conclusion 
In conclusion, immunoprophylaxis and immunotherapy targeting SesC might be a 
promising approach for prevention and treatment of S. epidermidis biofilms. 
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8. SesC structure and function 
 
This chapter is based on the following reference: Mohammad Shahrooei, Vishal Hira, Rita Merckx, Benoit 
Stijlmans, Peter W.M. Hermans, Johan Van Eldere. 2009. Inhibition of Staphylococcus epidermidis biofilm formation 
by rabbit polyclonal antibodies against SesC protein. Infection and Immunity. 77(9):3670-8. 
 
 
8.1. Introduction 
Although several genes in S. epidermidis have been mutated using allelic 
replacement (Pei and Flock 2001b;Tao et al. 2006;Vuong et al. 2000), transposon 
(Tn917) mutagenesis methods (Muller et al. 1993) or naturally occurring insertion of 
insertion sequences such as IS256 (Conlon et al. 2004), genetic manipulation of S. 
epidermidis is very difficult. For this reason we have a serious lack of knowledge about 
the basis of S. epidermidis virulence. 
In silico prediction of the structure and function of a protein, could be a valuable 
approach if homologues of the target protein have been already characterized. However 
data obtained by in silico prediction should be subsequently confirmed by experimental 
data. 
A complementary strategy which recently has been successfully used is transfer 
and expression of a gene in a surrogate bacterium. In this method a gene which encodes 
an unknown function protein is expressed in a strain that lacks that gene. Using this 
method, conversion of S. epidermidis strains from commensal to invasive was done by 
expression of the ica locus in strains lacking the ica-operon (Li et al. 2005) or S. aureus 
pathogenic genes were studied in the less virulent organism Streptococcus gordonii 
(Meier et al. 2001). 
In this chapter, the experiments performed for unraveling the structure and 
function of SesC, are explained. 
 
 
8.2. Materials and methods  
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8.2.1 In silico prediction of structure and function of SesC 
Online bioinformatics tools were used to characterize SesC. To identify the 
possible repeat domains, the RADAR algorithm was used (http://www.ebi.ac.uk/Tools/ 
Radar/index.html). A similarity and homology search was carried out using NCBI 
BLAST and FASTA (http://blast.ncbi.nlm.nih.gov/Blast.cgi, http://www.ebi.ac.uk/Tools/ 
fasta33/). Protein secondary structure was predicted using PSIPRED server version 2.6 
and CLC Combined Workbench version 3.6.2. (http://bioinf.cs.ucl.ac.uk/psipred/psiform. 
html, http://www.clcbio.com/index.php?id=93). Signal peptides were identified using the 
SignalP server (http://www.cbs.dtu.dk/services/SignalP-2.0/). Prediction of transmembra- 
ne helices was done using TMHMM server version 2.0 and SOSUI (http://www.cbs.dtu.d 
k/services/TMHMM-2.0/, http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html). Secon-
dary and tertiary structure was modeled using the 3D-PSSM Fold recognition server (http: 
//www.sbg.bio.ic.ac.uk/~3dpssm/). 
 
8.2.2. Construction of plasmids for sesC::tet allele replacement 
In order to analyze the SesC function in S. epidermidis, we tried to replace sesC 
by a tetracycline resistance gene (tet) by homologous recombination. The upstream 
fragment (991 bp) was amplified using primer pairs US-F 5’-GGTACCAAATAGTCCT 
CCTTCGGTGATG-3’ and US-R 5’-GGGCCCTTACACATACTCCTTTAATAAAGTT 
ACCTG-3’ with KpnI and ApaI (in italics and underlined), respectively. The downstream 
fragment (902 bp) was amplified using primer pairs DS-F 5’-GGATCCTCTTGTTATAA 
ACTTTGAGTAAGCGTT-3’ and DS-R 5’-CCCGGGAATTGATGGTCTTGCATTAAC 
TTC-3’ with BamHI and SmaI (in italics and underlined), respectively. The two 
fragments were cloned into the multiple cloning sites of temperature-sensitive E. coli-
Staphylococcus shuttle vector pBT2 (Bruckner 1997), resulting in a plasmid termed 
pBTU-D. A fragment of 2606 bp containing the entire tet(M) gene was amplified by PCR 
from the pCN36 (Charpentier et al. 2004), using the primers tet-F 5’CTATGACCCGGG 
AAATATTGAAGGCTAGTCAG-3’ and tet-R 5’-GTTTAAGGGCCCCAAATATGCTC 
TTACGTGC-3’ with SmaI and ApaI (in italics and underlined), respectively. The tet(M) 
gene was inserted into the vector pBTU-D, resulting in plasmid, pBT2∆sesC. Following 
passage through the restriction-negative strain S. aureus RN4220, pBT2∆sesC was 
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repurified and transformed into S. epidermidis RP62A by electroporation. Competent 
cells for electroporation were prepared by washing exponentially growing cells with 1% 
glycerol. Electroporation was performed at room temperature in a 0.2 cm cuvette (BTX 
Electroporation Cuvettes PlusTM), at a setting of 2.5 kV, 25 µF, 100 ohm (Ω) for 2.5 ms 
using a gene pulser (BTX Electroporator ECM 630). The transformants obtained by 
electroporation were selected on BHI agar plates containing chloramphenicol (10 µg/ml) 
at 30°C. For gene replacement by homologous recombination, one transformant was 
cultivated in BHI with chloramphenicol (10 µg/ml) and tetracycline (5 µg/ml) at 30°C for 
8 h and then with only tetracycline (5 µg/ml) at 43°C for 8 h. The culture was then diluted 
50-fold in BHI and grown overnight without antibiotic. Appropriate dilutions of culture 
were plated on BHI agar plates containing tetracycline (5 µg/ml) and grown at 43°C. The 
colonies from tetracycline plates were replica plated both onto tetracycline and 
chloramphenicol + tetracycline plates. Colonies that could grow only on tetracycline 
plates, but not chloramphenicol + tetracycline, were selected as candidates for further 
testing. PCR amplification and sequencing were used for verification. 
 
8.2.3. Cloning, expression and overexpression of sesC in S. aureus RN4220 and S. 
epidermidis RP62A 
The entire coding region of the sesC gene of strain 10b was amplified using 
primers sesC-EF 5’-TACGGGATCCCAGGTAACTTTATTAAAGGAGTATGTGTAA-
3’ and sesC-ER 5’-ACGTGGTACCACTAGAAGTTAATGCAAGACCATCAATTT-3’ 
which incorporate flanking BamHI and KpnI restriction sites (in italics and underlined), 
respectively. The amplicon was ligated into pCN68 and pCN50 vectors (Charpentier et 
al. 2004), yielding pCN68sesC and pCN50sesC. The plasmids pCN68, pCN50, 
pCN68sesC and pCN50sesC were electroporated into S. aureus RN4220 yielding RN-
pCN68, RN-pCN50, RN-pCN68sesC and RN-pCN50sesC, respectively. pCN50 and 
pCN50sesC were purified from RN4220 transformants, and electroporated into S. 
epidermidis RP62A yielding RP-pCN50 and RP-pCN50sesC, respectively. pCN68 
compared to pCN50 has a higher copy number in S. aureus, contains the ermC gene 
(ribosomal methylase-encoding gene of pE194 for erythromycin resistance) instead of the 
cat194 gene (chloramphenicol acetyltransferase-encoding gene of pC194 for 
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chloramphenicol resistance), and sesC in pCN68 is expressed under control of a 
constitutive promoter PblaZ. sesC gene expression in wild type and transformed strains 
was quantified by Taqman quantitative PCR. Briefly, overnight cultures of transformed 
strains and their parental strains in BHI were precipitated and washed once with PBS. 
The OD600 was adjusted to 1.0. Nucleic acid isolation and cDNA synthesis from 100 µl of 
each sample and quantification of both cDNA and genomic DNA were performed as 
previously described (Chapter 3.2.). 
 
8.2.4. Biofilm formation by transformants 
The amount of biofilm formed by RN- and RP-transformants and their parental 
strains was determined using a semi-quantitative adherence assay on 96-well polystyrene 
microtiter plates as previously described (Chapter 4.2.4.), in BHI medium or in BHI 
medium supplemented with 4% NaCl, 1% glucose or 3% ethanol to further induce 
biofilm development in RN4220 strain. 
 
8.2.5. Adherence of transformants to immobilized Fg, Fn, Cn and von Willebrand 
factor in the presence and absence of αSesC-IgGs 
Overnight cultures in BHI of transformed strains and their parental strains were 
precipitated and washed once with PBS. The OD600 was adjusted to 1.0 and the adherence 
was measured as follows. Wells of polystyrene microtiter plates were coated with human 
Fg (Sigma), Fn (Sigma), Cn (Sigma) and von Willebrand factor (VWF) (Sigma) in PBS 
overnight at concentrations ranging from 0.1 to 100 µg/ml. Blocking was done with 2% 
Bovine serum albumin (BSA) in PBS for 1 h at 37°C. After washing, either the pure 
cultures (100 µl per well) were pipetted into the plates or cultures were mixed with either 
pre-immune IgGs or αSesC-IgGs (5 µg/ml) and after 2 h of incubation at 4°C were added 
and allowed to adhere to the coated surfaces for 2 h at 37°C. After the incubation period, 
culture supernatants were washed and the remaining adherent cells were stained and 
quantified as previously described (Chapter 4.2.4.). 
 
 
8.2.6. Statistical analysis 
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 Statistical analyses were performed with GraphPad prism 4.2. as previously 
described (Chapter 6.2.5.). 
 
 
8.3. Results 
 
8.3.1. Subcellular localization, folding and structure prediction 
SesC is predicted to encode a 676 aa protein with a predicted molecular mass of 
75 kDa. The cytoplasmic precursor of SesC contains a 35 aa N-terminal signal peptide, a 
37 aa C-terminal LPXTG sorting signal and a large extracellular domain. The N-terminal 
signal is required for sec-dependent secretion and cleaved by signal peptidase. The C-
terminal signal is needed for cleavage between the threonine and the glycine of the 
LPXTG motif and attachment to peptidoglycan by sortase. One or two hydrophobic 
transmembrane helices and a positively charged cytoplasmic tail were identified within 
the N and C-terminus of the cytoplasmic precursor of SesC which are removed by signal 
peptidase and sortase. SesC is predicted to fold as either 30.9% -helix and 1.2% β-sheets 
and 67.9% coil (PSIPRED prediction) or as 56.6% -helix, 2.2% β-sheets and 41,2% coil 
(CLC prediction) (data not shown). Presence of mature SesC (≈68 kDa) in the cell wall 
fraction of S. epidermidis RP62A in the exponential and stationary phases of growth was 
shown using a Western immunoblotting technique (Bowden et al. 2005). In publicly 
available protein data banks, all homologues of SesC had less than 70% sequence identity 
to SesC and all homologues with identities higher than 26% were hypothetical proteins of 
unknown structure and function. The best homologue of SesC with a known function is a 
341 aa fragment of the clumping factor A (ClfA) (26.6% identity, 65.1% similarity in 
335-aa overlap). ClfA is a Fg-binding MSCRAMM of S. aureus. However, the putative 
Fg-binding site of ClfA is located outside this region of similarity. 
 
8.3.2. Construction and isolation of a natural S. epidermidis sesC mutant 
So far we have failed to knock-out sesC in S. epidermidis and we couldn’t find a 
natural S. epidermidis sesC-mutant. More than 10000 colonies from tetracycline plates 
were replica plated both onto tetracycline and chloramphenicol + tetracycline plates, 
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however none of them was a tetracycline-resistant, chloramphenicol-sensitive colony. We 
collected 239 clinical and commensal CNS isolates from hospitalised patients (n=215) or 
from the skin of healthy individuals (n=24). 105 out of 239 isolates from patients and 
healthy persons were identified as S. epidermidis and 134 isolates as other CNS including 
S. hominis (n=17), S. haemolyticus (n=58), S. warneri (n=43), S. capitis (n=15), S. 
saprophyticus (n=1). All 105 S. epidermidis isolates were sesC-positive whereas non-S. 
epidermidis isolates were either sesC-negative (80%) or sesC-positive (20%). 
 
8.3.3. Expression of sesC in S. aureus RN4220 and S. epidermidis RP62A 
Quantitative PCR data show expression of sesC in RN-pCN50sesC, RN-
pCN68sesC compared to their parental strain (RN4220) and overexpression of sesC in 
RP-pCN50sesC transformant compared to its parental strain (RP62A) (Figure 8.1.). 
 
 
 
 
Figure 8.1. Expression of sesC in RN4220 and RP62A and their transformants. cDNA and gDNA were 
isolated from 100 µl of overnight cultures of each strain, and then expression of sesC and copy number of 
gmk as internal standard were measured by real time quantitative PCR. The error bars indicate standard 
deviations. Data are the average of 6 measurements in 2 independent experiments. 
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8.3.4. Effect of SesC expression on biofilm formation of transformants 
Expression of SesC in RN4220 transformants completely inhibited biofilm 
formation in the presence of 4% NaCl but not 1% glucose or 3% ethanol, as biofilm 
inducers (Figure 8.2.). Overexpression of SesC had no effect on biofilm forming ability 
of RP62A (data not shown). 
 
 
 
 
Figure 8.2. Comparison of the effect of sodium chloride (NaCl), glucose (Gluc) and ethanol (EtOH) 
on biofilm formation in RN4220 and its transformants. Overnight cultures of RN4220 and its 
transformants were diluted to an OD600 of 0.005 and grown in 96-well plates. Biofilm formation of the 
strains in BHI and in BHI+4% NaCl, BHI+1% Gluc, and BHI+3% EtOH was quantified at OD595 as 
explained. NaCl, glucose and ethanol can induce biofilm formation by RN4220. X and Y axes represent 
media (BHI medium or BHI medium supplemented with 4% NaCl, 1% Gluc, or 3% EtOH) and mean 
amount of biofilm (represented by OD595), respectively. The error bars indicate standard deviations. Data 
are the average of at least 12 measurements in two independent experiments. 
 
 
8.3.5. SesC is a potential Fg-binding MSCRAMM 
To explore the function of SesC we expressed SesC in the sesC-negative S. aureus 
RN4220 and overexpressed sesC in the sesC-positive S. epidermidis RP62A by 
transformation of these strains with pCN68sesC and pCN50sesC. pCN68 has a higher 
copy number in S. aureus than pCN50. RN-transformants expressing SesC (RN-
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pCN68sesC and RN-pCN50sesC) and the RP-transformant RP-pCN50sesC exhibited 
higher Fg-binding ability compared to their parental strains (Figure 8.3.). The binding 
level of these transformants to other host ECM proteins (Fn, Cn and VWF) was similar to 
the binding level of their parental strains (data not shown). RN-pCN68sesC had 
significantly higher fibrinogen-binding ability than RN4220 and RN-pCN68 (p<0.001 
and p<0.01; 1-way ANOVA). RN-pCN50sesC and RP-pCN50sesC compared to their 
parental strains also exhibited significantly higher Fg-binding ability (p<0.05 and 
p<0.01; respectively; 1-way ANOVA). The Fg-binding ability of RN-pCN50sesC and 
RP-pCN50sesC was however not significantly different from their parental strains 
transformed by mock plasmids (RN-pCN50 and RP-pCN50). There was no significant 
difference between the Fg-binding levels of RN4220 or RP62A compared to RN-pCN50 
or RP-pCN50, respectively. 
Addition of αSesC-IgGs reduced the higher fibrinogen-binding ability of RN-
pCN68sesC and RN-pCN50sesC to the wild type strain level and also reduced the Fg-
binding ability of wild type and transformed RP strains to a lower level (Figure 8.3.). 
αSesC-IgGs had no effect on the binding ability of RN and RP wild types and 
transformed strains to Fn, Cn and VWF (data not shown). 
 
 
8.4. Discussion 
 sesC encodes a protein which is translocated on the surface by its N-terminal 
signal and covalently anchored by sortase to peptidoglycan. Gene expression studies 
demonstrated expression of sesC in biofilm cells in vitro and in vivo which was 
confirmed by protein expression studies. The in vitro biofilm inhibition studies suggest a 
role for SesC in attachment to polystyrene surface in both primary attachment and 
accumulation phases. The in vivo biofilm inhibition studies showed that SesC plays also a 
role in attachment to the polyurethane surface (catheter), and also experimentally verified 
the potential use of SesC as a promising target for immunization against S. epidermidis 
biofilms. 
The presence of this gene in all 105 tested S. epidermidis isolates confirms 
Bowden’s report (Bowden et al. 2005) and is consistent with the failure of our efforts to 
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Figure 8.3. Fg-binding ability of RN4220 (A) and RP62A (B) transformants in the presence and 
absence of αSesC-IgGs. Ability of RN4220 and RP62A strains and their transformants to bind 
immobilized Fg was measured using plates coated with Fg. X and Y axes represent the concentration of 
αSesC-IgGs and OD595, respectively. Binding activity for RN and RP strains was measured on plates coated 
with Fg at concentrations 10 and 1 µg/ml, respectively. The error bars indicate standard deviations. Data are 
average of 8 measurements in 2 independent experiments. 
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knock-out sesC in S. epidermidis indicating that sesC might be an essential gene. Yao et 
al.(Yao et al. 2005b) reported that sesC was absent in some S. epidermidis isolates, 
particularly in isolates from the skin of healthy individuals (9 out of 20 isolates). 
However, their data are doubtful since their data were generated based on transcriptome 
analysis and not identification of the gene by methods such as PCR amplification of the 
gene. Using other strategies such as antisense RNA technology or construction of a 
conditional mutant could be useful in future studies to identify the essential nature of 
sesC. 
Since our efforts to knock-out sesC in S. epidermidis have failed and we couldn’t 
find a natural S. epidermidis sesC-mutant, we expressed the gene in a S. aureus sesC-
negative RN4220 which is an ica-positive and ica-dependent biofilm forming strain and 
also overexpressed sesC in S. epidermidis strain RP62A. 
Our data show that sesC expression in RN4220 inhibits biofilm formation by this 
strain in the presence of NaCl as biofilm inducer but not when other biofilm formation 
inducers such as ethanol and glucose are used. There are several explanations for this 
phenomenon. The first explanation is that the expression of SesC switches the ica-
dependent mechanism of biofilm formation in RN4220 to the ica-independent mechanism 
of biofilm formation in RN-transformants. Several studies have shown that ica-positive S. 
aureus and S. epidermidis strains can switch from the ica-dependent to the ica-
independent mechanism of biofilm formation which can be inhibited by NaCl (Fitzpatrick 
et al. 2005;Hennig et al. 2007). We found a natural S. aureus among the clinical isolates 
which is an ica-positive, sesC-positive strain, and in which biofilm formation can be 
inhibited by NaCl similar to what we observed in the RN-transformants expressing SesC 
(data not shown). However, at the moment there are no other experimental data to support 
this assumption. 
In RP-transformants, the expression of sesC on the chromosome of bacteria might 
be downregulated in response to the constitutive expression of the sesC gene on plasmid. 
This might explain why biofilm formation in RP-transformants and the parental strain is 
not different. Constitutive, high expression of sesC, which encodes the LPXTG protein 
SesC might lead to the overexpression of SesC and consequently competition with other 
LPXTG proteins for location on the surface. The presence of these other LPXTG proteins 
 CHAPTER 8: SESC STRUCTURE AND FUNCTION  
 
 
 114
might be necessary for biofilm development in the presence of NaCl. However, biofilm 
formation of RN-transformants in the presence of other inducers (glucose and ethanol) 
was similar to their parental strain. 
Expression of sesC in the sesC-negative S. aureus RN4220 or overexpression of 
sesC in the sesC-positive S. epidermidis RP62A did lead to a clear effect on Fg-binding, 
but not to other host ECM proteins. However, the rSesC didn’t show any fibrinogen-
binding activity (data not shown). αSesC-IgGs could restore the Fg-binding level of the 
RN-transformants to the Fg-binding level of their parental strain and significantly 
reduced the Fg-binding ability of RP62A and its transformants but showed no effect on 
Cn, Fn and VWF-binding ability of tested strains. These data suggest that SesC can act as 
a Fg-binding MSCRAMM and αSesC-IgGs efficiently and specifically inhibit the SesC 
function and have no effect on the function of other MSCRAMMs. 
 Gene expression data support the involvement of SesC in the accumulation phase 
and persistence of biofilm, whereas biofilm inhibition studies show its involvement in 
primary attachment to naked and Fg-coated surfaces of polystyrene microtiter plates as 
well. An example for such a protein which plays a role in attachment to abiotic surfaces 
and also shows host matrix protein-binding activity is AtlE (Heilmann et al. 1997). 
 
 
8.5. Conclusion 
In conclusion, SesC might be a potential Fg-binding MSCRAMM, which plays a 
role in attachment to abiotic surfaces. Data from this part of the study are in line with 
other data and support a role for SesC in S. epidermidis biofim formation. However, 
further investigation is necessary to characterize the structure and analyse the function of 
SesC. 
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9. General conclusion and future perspectives 
 
 
9.1. General conclusion 
The following considerations highlight the need for vaccine development and 
prophylactic measures against S. epidermidis infections. 
Compared with S. aureus, S. epidermidis does not produce as many toxins and 
tissue-damaging exoenzymes and S. epidermidis infections may rarely become life 
threatening. However, S. epidermidis is now considered as the major cause of device-
related infections, infections which have increased in number, owing to the increased use 
of such devices. Besides, due to the formation of biofilm such infections are notoriously 
difficult to treat and currently, the only effective method for curing biofilm infections is 
to remove and replace the infected device, placing the patient at increased risk for 
complications due to these additional procedures. 
 There is evidence suggesting that S. epidermidis can transfer genes to S. aureus 
(Hanssen et al. 2004). Since S. epidermidis is a ubiquitous human skin commensal with 
high frequency of antibiotic resistance, it can act as a reservoir and carrier of antibiotic 
resistance genes to S. aureus. On the other hand, although so far this gene transfer 
appears to be a one-way street, it suggests that there is the possibility that virulence genes 
may be transferred from S. aureus to S. epidermidis. Gene transfer between S. aureus and 
S. epidermidis may have an enormous impact on public health. 
Currently, there is no anti-S. epidermidis vaccine. Nabi’s EpiVAX™ is a 
conjugate vaccine (patented antigens, PS-1 and GP-1) which entered into phase I clinical 
trials. Other research groups (Guss and Flock, U.S. Patent Application 20090214584) 
also patented other antigens as potential vaccine targets against S. epidermidis infections. 
However, no more data are available. 
In this study, using reverse vaccinology, SesC was identified as the best potential 
antigen for vaccination and production of protective antibodies against S. epidermidis in 
FBI. Characteristics of SesC as the best target are: 
1. sesC gene was present in all tested S. epidermidis isolates, indicating its 
possible essential role in S. epidermidis. 
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2. SesC protein is a surface-exposed protein which is expressed in both 
planktonic and sessile bacteria in vitro and in vivo. 
 
3.  sesC is highly expressed during the early and late phases of FBI, 
indicating its possible importance to pathogenicity. 
 
4. Rabbit polyclonal αSesC-IgG antibodies could prevent adherence of S. 
epidermidis to polystyrene surface, indicating its possible role in 
colonization of abiotic surface. 
 
5. αSesC-IgGs could inhibit biofilm formation of S. epidermidis in vitro in 
polystyrene plates during an overnight incubation, indicating its 
possible role in accumulation and maturation of biofilms. 
 
6. αSesC-IgGs could destabilize established (1-day old) biofilms, 
indicating its possible role in establishment of S. epidermidis biofilms. 
 
7. Subcutaneous injection of αSesC-IgGs at the insertion place of the 
catheters fragments could significantly reduce the number of attached 
bacteria to the catheter fragments in 1-day old biofilms, indicating the 
possible application of αSesC-IgGs for the treatment of established 
biofilms. 
 
8. Vaccination with SesC could elicit protective immunity in rat animal 
model for FBI, indicating its potential as a vaccine antigen. 
  
9. αSesC-IgGs had no effect on biofilm formation of a ses-negative 
clinical isolate of S. warneri, indicating the specificity of the binding of 
antibodies to SesC. 
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10. S. aureus RN4220 transformants expressing SesC or RP62A 
transformants overexpressing SesC could bind Fg and not other ECM 
proteins better than their parental strains. The higher Fg-binding level of 
transformants could be restored to the parental Fg-binding level by 
αSesC-IgGs, indicating the specificity of the binding of antibodies to 
SesC and the fact that SesC might be a potential Fg-binding 
MSCRAMM. 
 
11. In the presence of sodium chloride but not other biofilm inducers such 
as ethanol and glucose, S. aureus RN4220 transformants expressing 
SesC couldn’t form biofilm compared to the parental strain, suggesting 
that mechanisms of biofilm formation in transformants and their 
parental strain might be different or that expression of SesC inhibits the 
effect of NaCl on ica operon expression. 
 
Several studies have shown that there are two mechanisms (ica or PIA-dependent 
and ica-independent or proteinaceous) of biofilm formation in S. epidermidis. Although 
the ica or PIA-dependent mechanism of biofilm formation is currently the best-
understood mechanism, recent studies have shown the presence of S. epidermidis and S. 
aureus strains which possess and express the ica operon, but are incapable of biofilm 
development or that switch from the ica-dependent to ica-independent biofilm 
development mechanism (Fitzpatrick et al. 2005;Hennig et al. 2007). 
By examining the environmental regulation of biofilm development it has been 
demonstrated that sodium chloride is an activator of ica operon transcription and involves 
the production of PIA/PNAG, whereas it can’t induce the proteinaceous mechanism of 
biofilm formation (Conlon et al. 2004;Fitzpatrick et al. 2005;Hennig et al. 2007;O'Neill 
et al. 2007). However, the biofilm formation of strains which switch from ica-dependent 
to ica-independent or those which develop a biofilm by the ica-independent mechanism 
can be induced by environmental regulators such as glucose and ethanol (Fitzpatrick et al. 
2005;Hennig et al. 2007). 
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We have recently studied biofilm formation of 58 clinical isolates of 
Staphylococcus spp. in BHI or BHI supplemented with 4% NaCl, 1% glucose, or 3% 
ethanol (data not shown). We found a sesC-positive, ica-positive S. aureus isolate in 
which the biofilm formation can be induced by glucose but inhibited by sodium chloride 
similarly to biofilm formation in the RN-transformant expressing SesC (data not shown). 
These data support our hypothesis, that there might be a link between SesC and ica-
independent biofilm formation in S. aureus. 
Our data show the involvement of SesC in attachment to naked and Fg-coated 
surfaces of polystyrene microtiter plates. An example for such a protein which plays a 
role in attachment to abiotic surfaces and also shows host matrix protein-binding activity 
is AtlE (Heilmann et al. 1996;Heilmann et al. 1997). 
All these data are in line and support each other, suggesting that SesC is a 
promising antigen for vaccination against S. epidermidis biofilm formation and 
production of protective antibodies against S. epidermidis established biofilms. However, 
the precise role of SesC in biofilm formation and the mechanism of function of αSesC-
IgG antibodies in vivo remain to be identified. 
Preliminary results from an in vitro opsonophagocytosis assays which mimic the 
in vivo defense strategy suggest an opsonic activity of αSesC-IgGs (data not shown). 
Prevention of initial attachment and biofilm formation in vitro by αSesC-IgG in the 
absence of immune system components suggests a neutralizing effect which means 
probably binding of αSesC-IgGs to SesC inhibits the function of SesC and thus biofilm 
formation. Incubation of bacteria with αSesC-IgG had no effect on bacterial growth. 
 
 
9.2. Future perspectives 
 Figure 9.1. shows different steps of reverse vaccinology (Mora et al. 2003), 
starting from in silico prediction of potential antigens and ending with vaccine 
development. 
Future investigations are necessary: 
1. To unravel the precise structure and function of SesC. Construction of a S.  
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Figure 9.1. Flow chart of the genome-based approach to vaccine development. This approach involves 
the in silico analysis of microbial genome sequences followed by the high-throughput expression of the 
genes of interest. The recombinant proteins are then used to immunize animals and the post-immunization 
sera are analyzed to assess the ability of the polypeptide to elicit a quantitative and qualitative immune 
response (Mora et al. 2003). 
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epidermidis sesC-conditional mutants or methods such as antisense RNA 
technology can help us to unravel the role of SesC in biofilm formation. 
Knowing the protein’s structure and function opens the door to design more 
efficient strategies to target its function.  
 
2. The antigenic epitopes of SesC must be identified and tested individually. 
Knowing the function and structure of SesC can help us to design and use 
short peptides that contain the active site of protein for immunization. 
 
3. Since SesC was selected as the best antigen among five candidates only based 
on an in vitro assay, it might be worth to test the potential use of the other 4 
candidates for biofilm inhibition in vivo. If immunization with other proteins 
shows any anti-biofilm activity, a short peptide can be designed containing 
different epitopes from different proteins which most likely elicits higher 
protection compared to a single protein as a target. 
 
Our in vivo rat model, although closely resembling the subcutaneous models for 
FBI and mimicking intra-operative contamination with skin flora, doesn’t mimic 
conditions found in the human intravascular system. Intravascular devices are 
nevertheless the most frequently used medical devices. In addition, the immune response 
at the site of infection in our subcutaneous rat model may not reflect the immune 
response to the intravascular device-related infections in peripheral blood. Hence, it 
might be worthwhile to investigate the immune response in other rat FBI models for 
example a model that mimics intravascular conditions (Rupp and Fey 2001;Ulphani and 
Rupp 1999). 
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